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ABSTRACT  
 
 
THE DESIGN, SYNTHESIS, AND CHARACTERIZATION OF POLY(CARBONATE-
ESTER)S BASED ON DIHYDROXYACETONE FOR USE AS POTENTIAL 
BIOMATERIALS 
 
Jennifer Rose Weiser, Ph.D.  
Cornell University 2013 
 
The creation of new devices and materials with desirable biomedical characteristics, such 
as biocompatibility and easily tunable physico-chemical parameters, has played a key role in the 
advancement of the biomedical industry. In recent years, the combination of classical 
engineering principles with polymer chemistry has led to a wide range of materials that influence 
the manner in which drugs are delivered, tissues are engineered, and surgery is performed. The 
work presented in this thesis is focused on the design, synthesis, and characterization of a 
poly(carbonate-ester) biomaterial based on lactic acid (LA) and a carbonate form of 
dihydroxyacetone (DHAC) as vehicles for controlled release.  
The goal of this work was to synthesize a variety of pLAx-co-DHACy copolymers and 
characterize their behavior to better understand their structure/function relationships. The results 
show that random copolymers based on dihydroxyacetone and lactic acid are easily and reliably 
producible, with unique characteristics. In vitro degradation studies showed that the 
poly(carbonate-ester)s had an unexpected degradation pattern, in that the carbonate bond was 
more labile to hydrolysis than that of the ester bond. The resulting degradation pattern made 
from these biomaterials did not appear to have an acidic interior environment, due to a lack of 
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visible viscous core commonly seen with bulk degrading lactic acid based polymers. Due to the 
insolubility of the poly(carbonate-ester)s, exploration of copolymer degradation was determined 
by the development of a newly discovered technique to quantify dihydroxyacetone release from 
the matrix using the bicinchoninic acid assay. 
Finally, the release kinetics and mechanism from these poly(carbonate-ester)s was 
studied following the incorporation of two different model proteins, bovine serum albumin and 
lysozyme. Their release behaviors and activities were analyzed to explore the controlled release 
capabilities of these materials and to identify their potential for the effective release of proteins.   
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CHAPTER 1 - BACKGROUND 
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1.1 Introduction 
Biomaterials are defined as any natural or synthetic substance, other than drugs, that treat, 
augment, or replace any tissue, organ or body function.
1
 A biomaterial’s chemical structure 
governs its properties and functions. Biomaterials are commonly found in the pharmaceutical 
industry. Examples include coatings for tablets or transdermal patches. They are also common in 
the biomedical device industry, acting as materials for vision correction, kidney dialysis, stents, 
pacemakers and thousands of other applications.
2-5
 As of the 1990s, there are numerous functions 
for biomaterials found in about 2,700 different kinds of medical devices, 2,500 separate 
diagnostic products, and 39,000 different pharmaceutical preparations, with more than half of 
biomaterial applications made of or containing some polymeric component.
3
 The estimated 
annual sales of biomaterials as medical devices or diagnostic products equates to over 100 billion 
US dollars.
3
 More currently, medical devices comprised solely of polymeric materials is a $1 
billion dollar industry that has a growth rate of 10-20% each year.
6
   
Physicians often seek to cure ailments or improve a patient’s quality of life by replacing a 
defective body part with a substitute. However, up until this past century, the limitations on 
doctors was to use materials only found in nature, whose design may not necessarily be for the 
specific purpose the patient requires. Throughout the late 19
th
 and 20
th
 centuries, the creation of 
new biomedical materials has undergone a renaissance, driven by advances in polymer 
chemistry. Basic discoveries, like the process of vulcanization, were the impetus for renewed 
interest in creating semi-synthetic materials. In the early 20
th
 century, the advances in the field of 
polymer chemistry led to the introduction of polymers as they are thought of today. Yet, it was 
not until the mid 20
th
 century that polymeric materials began to be included in medical 
applications. Numerous planned and unplanned events led to the creation of new synthetic 
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polymers, and with those new ideas came potential biomaterial applications for use by the 
medical field.  
From its fledgling start in the 20
th
 century, synthetic polymers began appearing in 
hundreds of other biomedical applications such as dialysis tubing, drug eluting heart stents and 
joint replacement. Physicians, motivated by a need for custom-made materials for specific 
medical applications, turned to chemists, materials scientists, chemical engineers, and 
researchers in other disciplines to help create biocompatible, polymeric biomaterials.
7-10
 Over the 
past quarter century, there has been extensive research studying the biological interactions 
between the human body and each biomaterial. This better understanding of the tissue-
biomaterial interactions helped to revolutionize how researchers create new biomaterials, 
especially biodegradable polymers. This insight led to the modification of natural substances 
specifically designed for use in a wide range of implantable applications including orthopedic 
and dental devices, drug-delivery systems, and tissue engineering scaffolds.
4
  
The field of polymer chemistry encompasses the synthesis and characterization of newly 
developed polymers. A polymer’s structure is manipulated to fit the need for the material or 
create certain properties that are desired from the material. Something as simple as a 
homopolymer, a polymer made from a single type of monomer, already may fit a need, however, 
it is often found that copolymerizing two or more types of monomers offers the ability to fine 
tune the intrinsic properties of the material. The ability to tune the ratio of the different 
monomers within the copolymer backbone help to create a valuable new material. Another 
important parameter of copolymers that is often manipulated is the architecture of the backbone. 
Copolymers are found in numerous configurations, such as a block copolymer, where two or 
more homopolymers are linked covalently, alternating copolymers, where the monomer subunits 
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are alternating, statically random copolymers, where the monomer subunits follow a statistical 
rule as to how they are arranged in the backbone, or graft copolymers, where side chains of a 
different structure emanate from the main backbone. By manipulating the architecture of the 
copolymer, different properties are made that can meet the need of the material, such as 
crystallinity, strength of the material, flexibility, etc. 
Along with the type of synthesis used to create new polymer biomaterials comes the 
characterization of the materials. Understanding the intrinsic properties of new polymers is 
important to produce a material reliably. One example is nuclear magnetic resonance (NMR), 
which creates a profile of the material based on the principle that particular chemical groups and 
arrangement of atoms resonant at known radio frequencies in an applied magnetic field. NMR 
can help to verify the polymer chemical structure synthesized, elucidate the arrangement of 
monomers in the backbone of copolymers, and in certain cases, quantitatively determine the 
molecular weight of a polymer. In most cases a polymer’s molecular weight is qualitatively 
assessed by size exclusion chromatography, or gel permeation chromatography (GPC). GPC 
separates polymers based on hydrodynamic volume and the process creates a profile to 
determine the number average molecular weight (Mn), weight average molecular weight (Mw), 
and polydispersity index (PDI) of the polymer. All of these parameters are intrinsic to the type of 
polymer synthesized and are important in accurately characterizing the polymeric material.  
Other intrinsic properties of the polymer are important to help understand how a polymer 
will behave under different environmental conditions. How a polymer responds to temperature is 
determined by thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). 
TGA determines a polymer samples change in weight, or degradation, in response to an increase 
in temperature. The polymer degradation profile offers insight into the thermal stability of a 
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polymer and is often represented by the degradation temperature (Td). DSC is used to determine 
a sample’s melting temperature (if present) and glass transition temperature. A polymer’s 
melting temperature (Tm) represents the change from a crystalline or semi-crystalline state to an 
amorphous state. This property helps determine the type of polymer created, either a 
thermoplastic, or a material that may be heated, molded, and cooled again, or a thermoset, or 
material that is irreversibly cured and decomposes when heated. Thermoplastic materials are the 
only materials that have a Tm. DSC is also used to determine the glass transition temperature (Tg), 
which is the point where a polymer undergoes a transition from atomistic chain movement to 
segmental chain movement. Knowing this temperature is important to determine long-term 
stability of the polymer, as well as to understand how the material will behave at any given 
temperature. 
 
1.2 Classic approach to biomaterial synthesis 
Classically, the process of biomedical device innovation is driven by clinical demand in 
which a patient or physician defines a need, which then initiates an invention. Yet, it is here that 
the development of new polymeric biomaterials diverges. The first path to synthesizing a new 
polymer-derived biomaterial involves having a medical need clearly defined and then rationally 
designing the material based on the need. The second path involves rationally designing unique 
materials that are biocompatible and don’t enlist an immune response; however, these materials 
often do not have specific medical applications clearly defined. From this latter path, it is the 
material characterization and understanding of its inherent properties that allow for the 
exploration of potential therapeutic biomaterial applications. This approach also includes the 
exploration of previously synthesized materials for new medical purposes for which they were 
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not originally intended. 
The archetypal rational design of polymeric biomaterials includes the creation of 
materials such as the first biodegradable surgical sutures derived from polyesters of glycolic 
acid. Though the first poly(glycolic acid) polymer was developed by Dupont in 1954, it wasn’t 
until the 1960s that researchers Dr. Schmitt and Dr. Polistina, and later on Dr. Frazza, of the 
American Cyanamide Corporation, were able to create Dexon, the first synthetic bioresorbable 
suture.
9, 11
 This discovery began an entire field of work devoted to improving this vital and most 
basic surgical device. Further examples of significant polymeric biomaterials that have been 
rationally designed include the drug delivery device, GLIADEL
®
. Invented by Dr. Langer and 
Dr. Brem, the creation of this device used rational design to synthesize a specific polymer to 
address the problem of prolonged drug delivery to glioblastoma multilamela form of brain cancer 
patients. The invention is one of the first of its kind to be a directly implantable, surface eroding, 
drug eluting device.
12-14
 GLIADEL
®
 was intentionally designed to have a hydrophobic 
polyanhydride backbone, which exhibits surface eroding characteristics, which is necessary to 
maintain a constant, extended, zero order release of a drug. This polymeric drug delivery system 
revolutionized the treatment of gliomas, by allowing release of the drug directly into the resected 
tumor region of the brain, thereby avoiding the blood brain barrier.   
 
1.3 Alternate approaches to biomaterial synthesis 
The counter approach to this method of creating new biomaterials is to either create a 
completely unique, biocompatible material and explore its structure function relationships or take 
an already known material and explore new applications. The ability to be open-minded and 
flexible with old and new biomaterials has led to numerous advances in medicine. An example of 
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one of the first polymeric materials created in this manner was polymethylmethacrylate 
(pMMA). Originally, pMMA was used in the cockpit windshield of World War II fighter planes. 
Its presence in the eyes of injured pilots drew the attention of the physician, Sir Harold Ridley. 
Sir Ridley noticed these plastic pieces of shrapnel did not enlist an immune response even years 
after the ocular trauma occured.
5
 This eventually led to the development of other pMMA-based 
materials for such applications as contact lenses. The example of pMMA finding a niche in 
ocular repair and altering the corrective vision industry is just one of these discoveries that 
helped improve medical care by using a material not originally designed for this new medical 
purpose.
5
 Other examples include the repurposing of the rationally designed surgical sutures to 
be the starting point for all of modern day tissue engineering. Dr. Charles Vacanti, an 
anesthesiologist by training, took extra polymeric suture materials from the operating room and 
began to grow chondrocytes on these structures. This early attempt at tissue engineering was in 
response to the need for synthetic cartilage which could be made from naturally occurring 
materials and shaped into the desired form to mimic native tissue. These materials, already 
known to be biocompatible with cells and FDA approved, were one of the first rudimentary 
tissue engineering scaffolds.
7, 15
  
In modern medicine, polymeric biomaterials play an important role in the progression of 
health care. The advancement of polymer synthesis techniques and the discovery of new, 
biocompatible building blocks alter the way through which new biomaterials are created. On one 
hand, inventing a new material with specific properties for a specific application is vital in 
addressing a need for certain patients or physicians. However, as polymeric chemistry evolves 
and the number of unique biocompatible polymeric materials synthesized continues to grow, the 
ability to understand a material’s characteristics and to find a useable function for these materials 
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is just as crucial to transforming the medical industry. 
 
1.4 Goals of this study 
The ability to successfully create functional polymer-based biomedical devices has been 
a significant challenge in recent years. The need to create materials that are biocompatible and do 
not enlist immune responses or unfavorable side effects, while still performing their intended 
purpose, is the key to creating successful biomaterials. Biomaterials comprised of biologically-
derived monomers are of particular interest because each building block has the ability to impart 
unique characteristics that may improve processability, the mechanical properties, and overall 
effectiveness of the material for its intended application.
3, 7, 14, 16-22
 By adjusting the ratio of 
monomers, the molecular weight, and type of monomers, a copolymer’s intrinsic properties may 
be altered and optimized. The specific goal of this thesis project was to create various 
copolymers based on the glycolytic intermediate, dihydroxyacetone, and analyze their 
characteristics for potential biomaterial. 
Dihydroxyacetone (DHA) is a glycolytic metabolite that, in its natural form, is an 
intermediate in the conversion of glucose to pyruvate in the human body. DHA is used as the 
active ingredient in sunless tanners, and is naturally derived from sugar beets, sugar cane, and by 
the fermentation of glycerin. In recent years DHA and a carbonate form of DHA, DHAC, have 
been used as a building block for a number of different types of polymers.
20, 22-25
 Early work 
aimed at creating an adhesive biomaterial saw the creation of homopolymers based on the dimer 
form of DHA due to DHA being in equilibrium with its dimer in solution.
25
 Linear hompolymers 
based on DHAC were made possible by protecting the ketone group of DHA and creating a 
cyclic form of the monomer before polymer synthesis.
26
 However, upon deprotection, these 
9 
 
materials were insoluble in most common solvents and did not possess the desired adhesive 
properties. The next generation of this biomaterial saw the creation of a block copolymer based 
on monomethoxy polyethylene glycol (MPEG) and DHAC.
21
 This material was found to be very 
effective for the treatment of seroma and for hemostasis.
20, 22, 27
 This success has guided the next 
generation of DHAC based copolymers. 
For this thesis project, random poly(carbonate-ester)s based on DL-lactic acid (LA) and a 
protected carbonate form of dihydroxyacetone were synthesized for use as a potential biomaterial 
(Figure 1.1). Characterization of the protected and deprotected form of these copolymers was 
conducted using standard techniques such as 
1
H and 
13
C nuclear magnetic resonance 
spectrometry (NMR), gel permeation chromatography (GPC), thermogravimetric analysis 
(TGA), and differential scanning calorimetry (DSC). The copolymers were then deprotected by a 
different technique than previously explored for this class of polymers by using iodine and 
acetone, to produce various, random, poly(carbonate-ester) backbone materials of DHAC and 
LA. All copolymer compositions are defined according to the following abbreviations: LAx = 
mol % lactic acid; DHACy = mol % dihydroxyacetone carbonate.  (pLAx-co-DHACy).
20-22
 The 
poly(carbonate-ester) backbone allowed for a long term degradation studies to be conducted as 
well as model protein release studies.  
 
 
Figure 1.1. Structure of LA-DHAC based copolymers (pLAx-co-DHACy) 
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Figure 1.2. Illustration of surface erosion vs. bulk erosion during polymer degradation. (Adapted 
from Von Burkersoda and Göpferich, et al.)
28
 
 
 Polymer erosion, defined as the loss of mass from a polymer system, proceeds via two 
main pathways, surface erosion or bulk erosion, as shown in Figure 1.2. The manner in which a 
polymer degrades, defined as the chain scission of the polymer backbone, determines the unique 
erosion profile of each polymer system. Surface eroding polymers proceed at a constant velocity, 
where only material from the surface of the polymer is lost. Thus these materials will get smaller, 
but will keep their original geometric shape. The advantage to this type of erosion is that the 
process is predictable, which is desirable for controlled drug delivery. In contrast, bulk erosion is 
a much more complex process. Bulk eroding polymers do not have their degradation and erosion 
confined to the surface of the device. This may lead to the geometric shape and size of the device 
remaining constant, while the matrix interior is already degrading. The bulk erosion process will 
then proceed at a variable velocity that is more complex to predict than surface eroding 
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materials. However, both pathways of erosion depend on a number of parameters such as 
polymer degradation, copolymer composition, swelling, the dissolution and diffusion of 
oligiomers and monomers, autocatalysis by acidic degradation products trapped in the matrix, 
etc.
28-30
 
 A two month in vitro degradation study was conducted on pLAx-co-DHACy tablets 
formed via direct compression and each sample’s degradation kinetics were characterized via 
mass loss and changes in tablet dimension. The trends seen in the mass loss data suggests a more 
surface eroding-like material rather than bulk erosion-like material. Visualization of the 
degradation was conducted using scanning electron microscopy (SEM) to characterize the 
internal degradation pattern of this class of biomaterial. The results show that increasing the 
DHAC content, and therefore the carbonate content in the copolymer backbone, increases the 
rate at which the copolymers degrade. The SEM data correlates with this result, as it too shows 
the increased degradation of copolymers richer in carbonate bonds. The SEM data also shows 
that the degradation profile does not fully align with either a bulk eroding or surface eroding 
matrix. There is no presence of a liquid core that would indicate a significant decrease in pH at 
the center of the tablet due to excess acid production from the LA in the degrading copolymer 
backbone.  
 Due to the insoluble nature of deprotected pLAx-co-DHACy in most common solvents, 
the molecular weight change of the degrading copolymer was unable to be monitored using 
tradiational methods, such as GPC. To address this issue, a new method to assay the degrading 
samples was developed via the repurposing of the bicinchoninic acid assay. This assay, generally 
used for protein quanitification, was seen to reliably quantify α-hydroxy ketones, such as DHA, 
in solution. Under alkaline conditions, the BCA assay determines the total concentration of an 
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analyte via the reduction of Cu
2+
 ions.
31, 32
 The reduced Cu
2+
 to Cu
1+
 reacts with bicinchoninic 
acid which forms a complex that absorbs light strongly at 562 nm. The absorbance of this 
complex is then used to quantify an analyte’s concentration either using a standard curve or 
Beer’s law (A=*b*c).  
By employing this assay, the degrading, directly compressed tablets made of deprotected 
pLAx-co-DHACy were able to be monitored and an accurate release profile of DHA, a 
degradation product of DHAC, created. A zero-order release pattern was observed for pLA15-co-
DHAC85 while a first order release of DHA was observed for pLA25-co-DHAC75 and pLA50-co-
DHAC50. 
Finally, a more detailed profile of the intrinsic characteristics of pLAx-co-DHACy was 
obtained by the implementation of two protein release studies. Two model proteins, bovine 
serum albumin (BSA) and lysozyme, were incorporated into the copolymer matrix prior to direct 
compression and the tablets were placed in physiologically simulated in vitro conditions. The 
release profiles for both model proteins show that increasing DHAC content in the backbone 
increases the rate at which the protein releases. The trend for all of the ratios follows a first order 
release for both proteins, with the BSA generally releasing faster. This study also provided 
information about the interior environment of the degrading copolymer matrix via the assessment 
of lysozyme activity throughout the study. It was observed that lysozyme remained highly active 
throughout the faster release from pLA-co-DHAC85 and pLA25-co-DHAC75, while it retained at 
least 50% of its activity for well over the first month of release from the slower releasing pLA50-
co-DHAC50 copolymer matrix.  
 Due to the complexity of the degradation and erosion pattern, mathematical modeling 
was employed to garner a better understanding of how these materials behave. The use of 
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mathematical models helps predict the release kinetics of a drug before the release systems are 
completely understood. One way to model drug release is to use mathematical functions to 
describe the dissolution process. The most basic model is the zero-order release model that is 
used to model drug dissolution from dosage forms that do not disaggregate and release drugs 
slowly over time. This model is used to describe the drug dissolution from some transdermal 
systems, as well as matrix tablets with poorly soluble drugs, or certain polyanhydride systems.
33, 
34
 A more complex system is the first order model and is often used to describe adsorption or 
elimination of drugs and is useful in modeling pharmaceutical dosage forms such as those 
containing water-soluble drugs in a porous matrix.
33
 
 One of the earliest mathematical models used to describe drug release from a matrix 
system was the Higuchi model. Originally created for planar systems, it has since been expanded 
to other geometries. The Higuchi model is based on six principles: drug diffusion takes place 
only in one dimension, drug particles are smaller than the pore size of the matrix, initial drug 
concentration in the polymer matrix is higher than the drug solubility, drug diffusivity is 
constant, near perfect sink conditions are maintained and the matrix swelling and dissolution are 
negligible. This model is used to describe drug release from matrix tablets with water soluble 
drugs and transdermal systems.
33, 35
 
 Hixson and Crowell recognized that a particle’s area is proportional to the cube root of its 
volume and created the Hixson-Crowell model that describes drug release from systems when 
there is a change in surface area or diameter of the particle or tablet. This model applies to 
tablets, where dissolution occurs in planes that are parallel to the drug surface and the tablet’s 
dimensions diminish proportionally.
33, 36
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 Korsmeyer and Peppas derived a simple relationship to deduce the mechanism of drug 
release from cylindrical shaped matrices. By fitting drug release data to the model, parameters 
are calculated that describe the release mechanism of the drug. The release mechanisms may 
correspond to a Fickian diffusion mechanism, a non-Fickian transport, a Case II (relaxational) 
transport, pseudo-Fickian transport, or to super case II transport, which are detailed in Table 
1.1.
37-40
 
Modeling the mechanism of release from the pLAx-co-DHACy copolymer matrix 
suggests that the release mechanism is quite complex, and may depend on numerous other 
factors such as drug diffusion, porosity, the crystallinity, polymeric swelling, and polymer 
erosion. 
 
 
 
 
 
 
Table 1.1. Korsmeyer-Peppas drug transport mechanism from cylindrical polymer matrices. 
15 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 – INITIAL CHARACTERIZATION OF POLY(CARBONATE-ESTER)S  
 
 
 
 
 
 
 
 
 
 
 
 
Reproduced in part with permission from Biomacromolecules, 12(4), Jennifer R. Weiser, Peter 
N. Zawaneh, David Putnam, Poly(carbonate-ester)s of Dihydroxyacetone and Lactic Acid as 
Potential Biomaterials, 977-986.  Copyright (2011) American Chemical Society. 
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2.1 Introduction 
The creation of new devices and materials with desirable biomedical characteristics, such 
as biocompatibility and easily tunable physico-chemical parameters, has played a key role in the 
advancement of the biomedical industry. In recent years, the combination of classical 
engineering principles with polymer chemistry has led to a wide range of materials that influence 
the manner in which drugs are delivered, tissues are engineered, and surgery is performed.
7, 8, 11, 
17, 41-43
 The combination of engineering and chemistry, aided by the use of naturally occurring 
biocompatible monomeric building blocks, has yielded a number of advances in the field of 
biomedical engineering. 
Examples of two naturally occurring monomeric building blocks that have shown to be 
valuable in the area of polymeric biomaterials are dihydroxyacetone and lactic acid. 
Dihydroxyacetone (DHA), a glycolytic metabolite, has only in recent years been explored for its 
use as a polymeric biomaterial. In its natural form, DHA is an intermediate in the conversion of 
glucose to pyruvate, is used as the active ingredient in sunless tanners, and has been used as a 
building block for a number of different types of polymers in a carbonate form (DHAC).
20, 22, 24, 
25, 44
 
 
In contrast to the more recently developed dihydroxyacetone monomer, lactide, a cyclic 
di-lactone of lactic acid (LA), has been used for decades as a robust building block for the 
creation of a variety of tunable lactic acid containing polymers via a coordination-insertion 
controlled ring-opening polymerization.
9, 45, 46
 One traditional example, poly(lactic acid-co-
glycolic acid) (PLGA) copolymers, is one of the most well characterized and widely used 
biomaterials because of its low toxicity, easily controllable degradation rates, and its ability to be 
cleared via normal metabolic pathways.
16, 47-50
 Previous work by Grinstaff, et al, shows the value 
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of polymerizing lactic acid with other cyclic carbonates, such as glycerol derived monomers, to 
increase the hydrolytic degradation rate. The characteristics of these new lactic acid based 
copolymers for use as scaffolds for delivering drugs has been reported.
51
 From this initial work, 
other poly(carbonate-ester)s have been explored and developed as new biomaterials for various 
medical applications.
52-54
  
The properties imparted to the copolymer from each monomer are the main driving force 
in exploring the creation of random copolymers formed via ring opening polymerization of DL-
lactide and a protected cyclic carbonate of dihydroxyacetone. Previous studies show that the 
degradation characteristics enable both LA- and DHAC-based polymers to hydrolyze into safe 
products and are a central motivation to maximize the biocompatibility of the materials.
10, 22
  
It is the intent of this work to report the creation of poly(carbonate-ester)s derived from 
DHA and LA and to demonstrate the ease of synthesis for various molar ratios of the two 
monomers. Additionally, we report a new method through which to deprotect the DHAC in a 
way that is more compatible with polyesters. Previous work using DHA for the synthesis of 
copolymers exemplified the need to create a protected monomer due to DHA’s vulnerability 
toward nucelophilic addition at the C2 carbonyl and its capacity for forming a dimer in 
solution.
25, 26
  However, we considered that the previously reported method of acetal deprotection 
via acid catalyzed cleavage in the presence of water, while proven to be efficacious for the case 
of diblock copolymers based on a polycarbonate of DHA and ethylene glycol, may be unsuitable 
for copolymers containing the more hydrolytically susceptible ester-based copolymer 
backbone.
21
 This motivation led to an alternative deprotection method for the polymeric 
DHAC’s protecting group (a dimethoxy acetal) using elemental iodine in the presence of acetone 
and heat.
55 
Additionally, the in vitro degradation characteristics of this new material are reported. 
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Contrary to the behavior normally seen in compressed polyester tablets, specifically those 
comprised of poly(lactic acid), the copolymers of DHAC and LA appear to have a primarily 
surface erosion pattern of degradation rather than a bulk erosion pattern. The tablets also show 
no sign of a liquid core that would be the result of a faster degradation inside the copolymer than 
outside, which is the case for tablets comprised of poly(lactic acid).
10, 56, 57
 Lastly, contrary to 
most polycarbonate degradation studies, increasing the carbonate group content in the copolymer 
backbone increases the rate of degradation.
58-60
 
 
 
 
2.2 Experimental 
 
2.2.1 Materials 
Dihydroxyacetone dimer, p-toluene sulfonic acid, stannous octoate (Sn(Oct)2), ethyl 
chloroformate, iodine, and acetone (CHROMASOLV
®, for HPLC, ≥99.9%) were purchased 
from Sigma-Aldrich (St. Louis, MO) and used as received.  Triethylamine, tetrahydrofuran 
(THF), sodium carbonate (Na2CO3), dichloromethane (CH2Cl2), diethyl ether, and methanol 
were purchased from VWR (West Chester, PA) and used as received. Trimethyl orthoformate 
was purchased from Alfa Aesar (Ward Hill, MA) and used as received. DL-Lactide was 
purchased from VWR (West Chester, PA) and recrystallized in methanol. Phosphate buffered 
saline (PBS) without calcium or magnesium was purchased from BioWhittaker
®
 (Lancaster, 
MA).  
 
2.2.2 Characterization methods 
1
H and 
13
C NMR spectra were recorded on Mercury 300 MHz and Inova 400 MHz 
spectrometers, respectively. 
1
H NMR traces were normalized to the residual DMSO-d6 solvent 
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peak at and 13C NMR normalized to the DMSO-d6 residual peak at 39.52. Gel 
permeation chromatography (GPC) was carried out using SDV columns (Polymer Standard 
Service) 500A, 50A, and linear M (in series) with a THF mobile phase (1 ml/min), and 20 
polystyrene standards ranging from 1,000 to 1,000,000 Daltons (Polymer Standard Service Win 
GPC software fit to a 5
th
 order polynomial equation) as a reference for the number average and 
weight average molecular weight calculations, UV (Waters 486) and RI (Waters 2410) detection. 
Thermal gravimetric analysis (TGA) experiments were conducted on a TGA Q500 (TA 
Instruments) with a heating rate of 10 ºC/min and nitrogen flow rate of 50 mL/min. Differential 
scanning calorimetry (DSC) measurements were performed on a DSC Q1000 (TA Instruments) 
equipment at a heating/cooling rate of 10 ºC/min and nitrogen flow rate of 50 mL/min. SEM 
images were taken with a Leica 440 (5kV, 600 pA, Leica Microsystems) on samples sputter 
coated with gold-palladium (60-40) using a Denton Vacuum Sputter Coater Desk II. Static 
contact angle measurements were performed under ambient conditions with a Ramé-Hart contact 
angle goniometer equipped with a syringe and flat-tipped needle allowing for a minimum droplet 
size of 10 μl. The probe fluid use was purified water and applied directly to the surface of dry 
copolymer tablets. 
 
2.2.3 Synthesis of 2,2-dimethoxypropylene carbonate (III) 
This compound was synthesized following a previously published method.
21, 26
  In brief, 
DHA dimer (62.5g, 0.348 mol), trimethylorthoformate (76.1 mL, 0.695 mol), and p-
toluenesulfonic acid (250 mg) were dissolved with magnetic stirring in methanol (700 mL). After 
12 hours, sodium carbonate (750 mg) was added and the reaction mixture allowed to stir for an 
additional 12 hours after which the mixture was filtered, the solvent removed in vacuo, and the 
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remaining viscous, brown liquid recrystallized repeatedly from diethyl ether to afford 2,2-
dimethoxy-propane-1,3-diol (II) as a white, crystalline material. This compound was then 
cyclized by a 15 minute dropwise addition of triethylamine (27.8 mL, 0.2 mol) in THF (50 mL) 
into a stirring flask of 2,2-dimethoxy-propane-1,3-diol (14.3 g, 105 mmol) and 
ethylchloroformate (19 mL, 0.2 mol) in THF (200 mL) at 0 ºC. After the addition of 
triethylamine was complete, the reaction was allowed to stir at room temperature for an 
additional 3 hours after which the mixture was filtered and the THF removed in vacuo. The 
viscous, yellow product was recrystallized from ethyl ether three times to yield, 2,2-
dimethoxypropylene carbonate (III), a white, crystalline powder. Yield and characterization are 
reported in the aforementioned references. 
 
2.2.4 Synthesis of poly(DL-lactide-co-2,2-dimethoxy-1,3-propylene carbonate) (IV) 
(protected pLAx-co-DHACy) 
Prior to each reaction, a 5 mL pear shaped flask with magnetic stir bar was flame dried 
and evacuated for 10 minutes. Varying feed mole ratios of LA and 2,2-dimethoxypropylene 
carbonate (III), for a combined total of 3 mmol (pLA100, protected pLA85-co-DHAC15, protected 
pLA75-co-DHAC25, protected pLA50-co-DHAC50, protected pLA25-co-DHAC75, protected 
pLA15-co-DHAC85, pDHAC100), were added to the reaction vessel and allowed to evacuate for 
an additional 5 minutes. The reaction vessel was then sealed and partially immersed in a 130 ºC 
paraffin oil bath for approximately 1-3 minutes until a melt had formed at which time the 
reaction was allowed to stir magnetically. Following this step, Sn(Oct)2 was added immediately 
using a 20 μL micropipette and the vessel evacuated for 10 seconds to 50 mmHg exactly, then 
immediately sealed under vacuum. The reaction was allowed to proceed at 130 ºC for one hour 
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with stirring after which the reaction was cooled to room temperature. The solid, semi-
transparent copolymer was dissolved in 1 mL dichloromethane and precipitated by dropwise 
addition into 60 mL of stirring methanol before isolation by filtration and dried under vacuum. 
Reprecipitation was performed twice in the same manner and each time yielded a solid, white 
copolymer. The yield for each feed ratio ranged from 50-80% and each ratio was synthesized in 
triplicate. For the in vitro degradation study, the amount of initiator was altered to create 
consistent molecular weights (Mw ~70 kDa). For the degradation study, the amount varied from 
5.1 L, 6.4 L, or 12 L of Sn(Oct)2 for the protected pLA50-co-DHAC50, protected pLA25-co-
DHAC75, protected pLA15-co-DHAC85, reactions, respectively. These three ratios were chosen 
due to their physical characteristics during deprotection. Upon deprotection the ratios containing 
≥50% DHAC precipitated out of solution as a fine white powder and thereby were amenable to 
direct compression into uniform discs. Those with less that 50% DHAC in the backbone 
remained in solution until precipitation into cold diethyl ether whereby they became a very 
tough, solid white mass. Molecular weights obtained by GPC and thermal data are provided in 
Table 2.1 and Table 2.2. The 
1
H and 
13
C NMR spectra are similar for each copolymer and are 
exemplified by the spectrum found for protected pLA50-co-DHAC50 copolymer in Figures 2.1 
and 2.2, respectively. 
1
H NMR (DMSO-d6) : 5.05-5.21 (broad m; LA 1H), 4.12 (s; DHAC 2H), 
3.18 (s; DHAC 3H), 1.43-1.48 (broad; LA 3H). 
13
C NMR (DMSO-d6):  169 (LA, CO, 
multiplet), 153 (DHAC, O-CO-O, multiplet), 99 (DHAC, C), 68-69 and 71 (LA, CH, multiplet) 
62 and 60 (DHAC, CH2, multiplet), 49 (DHAC, OCH3), 16 (LA, CH3). Multiplets and ranges 
were designated as shown in Figure 2. 
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2.2.5 Synthesis of poly(DL-lactide-co-2-oxopropylene carbonate) (V) (pLAx-co-DHACy) 
V was prepared via conversion of the dimethoxy acetal to a carbonyl using molecular 
iodine in acetone. Deacetalization of IV with molecular iodine (1:1 w:w) was carried out in 
acetone (CHROMASOLV
®
, for HPLC, ≥99.9%).  A 25 mL round bottom flask was flamed 
under vacuum before being charged with IV (250 mg) and iodine (250 mg) in acetone (7 mL) 
and allowed to stir for 2 hours partially submerged in a 52 
o
C paraffin oil bath. For the 
copolymers containing 50% DHAC or more, the deprotected copolymer was too insoluble to 
remain in solution for the entirety of the set time period. For these copolymers, the insoluble, 
partially deprotected copolymer was allowed to settle to the bottom of the flask after the two 
hour reaction whereupon the acetone was decanted. The fine powder product was then washed 
repeatedly with fresh diethyl ether to remove any visible signs of residual iodine before being 
transferred to a 20 mL scintillation vial. Fresh ether (15 mL) was added, the vial capped and the 
suspension allowed to stir for an additional 3 days. During this time the ether was decanted twice 
daily and fresh ether was added as needed to remove excess iodine before being dried under 
vacuum. For the copolymers containing less than 50% DHAC, the deprotected copolymer 
remained in solution for the set time period. For these copolymers, all but 2 ml of solvent was 
removed in vacuo and the copolymer was precipitated by the slow dropwise addition of cold 
ether into the vigorously swirling flask containing the copolymer/iodine solution. The 
precipitated copolymer was washed with diethyl ether before dissolution in a minimal amount of 
dichloromethane and precipitated into stirring methanol (60 mL) three times. The copolymers 
were washed a final time with diethyl ether, isolated by filtration, and dried under vacuum. The 
yield for each deprotected copolymer was approximately 75%. Thermal data are shown in Tables 
2.1 and 2.2. Elemental analysis (Intertek QTI Laboratory
©
) of the material show minimal 
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residual iodine (<0.1%). The 
1
H NMR spectra are similar for each copolymer and are represented 
by Figure 2.4 for the pLA50-co-DHAC50 copolymer. Due to low solubility, a 
13
C NMR analysis 
of the deprotected copolymer was not possible.  
1
H NMR (DMSO-d6) : 5.05-5.21 (broad m; LA 
1H), 4.99 (broad; DHAC 2H), 1.43-1.48 (broad; LA 3H). 
 
2.2.6 Monomer distribution analysis 
13
C NMR was performed on the protected copolymers using an Inova 400 MHz 
spectrometer in DMSO-d6 for a period of 12 hours and the results are provided in Figure 2.3.  
 
2.2.7 In vitro degradation analysis 
The in vitro degradation study was designed to run for 56 days and followed three 
copolymer monomer ratios, pLA50-co-DHAC50, pLA25-co-DHAC75, pLA15-co-DHAC85 all with 
Mw ~70,000 g/mol. Each ratio was synthesized at least five times and the fine, white powders 
combined before being sizing through a 250 μm sieve. Tablets were formed using direct 
mechanical compression to 1000 psi for 10 seconds on 20 mg of copolymer at room temperature. 
The final cylindrical tablets had dimensions of approximately 5.32 ± 0.02 mm x 0.84 ± 0.02 mm 
(diameter x thickness) as measured by digital calipers. Each tablet was placed in 1X PBS buffer 
solution (1.5 mL, pH 7.4) and incubated with rotation (N=3) at 37 ºC. Every three days the 
buffer solutions were exchanged and a control was used to ensure a constant pH. At 
predetermined time points, the samples were removed from the buffer solution, rinsed with DI 
water, dried by KimWipe
©
 and lyophilized for three days. The mass loss and new tablet 
geometry were then recorded.  The percent mass loss was calculated using the following 
expression: 
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where m0 refers to the initial mass and mf refers to the final mass at a specific time point. 
 
2.2.8 Morphological characterization 
Scanning electron microscopy (SEM) was used to determine the morphology of the 
surface and the cross-section of each tablet at each time point (Leica 440). In brief, each tablet 
was placed on a small metal stub and sputter coated with gold-palladium (60-40) to a thickness 
of 10 nm using a Denton Vacuum Sputter Coater Desk II. For the cross-sectional view, each 
pellet was cut in half with a razor blade, immersed in liquid nitrogen and fractured in half again 
by hand before sputter coating.  
 
2.2.9 Surface characterization 
Static contact angle measurements were used to explore the surface of the three 
copolymer ratios used in the hydrolytic degradation study. Manual addition of a droplet of water 
to the top surface of each copolymer tablet allowed the contact angle to be measured. This 
experiment was repeated for each ratio to confirm the validity of the reading. 
 
2.3 Results and Discussion 
2.3.1 Synthesis of poly(DL-lactide-co-2-oxopropylene carbonate) 
The synthetic strategy employed to create copolymers of lactide and dihydroxyacetone is 
shown in Scheme 2.1. The DHAC monomer was prepared based on earlier work using a 
dimethoxy acetal protecting group to prevent the DHA from forming a dihemiacetal dimer.
21, 26
 
The protected DHA was then converted into a six-membered, cyclic carbonate ring to be used for 
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ring-opening polymerization (III).
26
  Stannous octoate (Sn(Oct)2) was used as the coordination 
catalyst due to its efficacy to promote ring opening polymerizations of both the cyclic lactide and 
DHAC monomers.
9, 21, 22, 26
   
Five monomer ratios of the pLAx-co-DHACy, (pLA85-co-DHAC15, pLA75-co-DHAC25, 
pLA50-co-DHAC50, pLA25-co-DHAC75, pLA15-co-DHAC85), were synthesized by adjusting the 
feed ratio of the two monomers while maintaining a constant Sn(Oct)2/monomer ratio. As a basis 
for head-to-head comparisons, LA and DHAC homopolymers (pLA100 and pDHAC100) were also 
synthesized. For the three ratios of copolymers that were investigated in the in vitro degradation 
study (pLA50-co-DHAC50, pLA25-co-DHAC75, pLA15-co-DHAC85), a constant molecular weight 
was maintained by varying the amount of Sn(Oct)2 as described in the methods section. Due to 
the higher melting temperature of the LA monomer as compared to the protected DHAC 
monomer, all molar ratios were synthesized by a melt injection of the Sn(Oct)2 at 130
 o
C to 
ensure the creation of a homogenous monomer mixture. The mole fractions of each monomer in 
the copolymers were confirmed via 
1
H NMR analysis of the -CH3 species present in the LA 
(1.43-1.48) and the protected DHAC (3.18), which is shown in Figure 2.1 and the average 
values reported in Table 2.1. GPC analysis of the protected copolymers with different feed ratios 
was performed and the relative molecular weight, shown in Table 2.1, shows a direct relationship 
exists between increasing DHAC content and Mw for each copolymer. In addition, the GPC 
traces, which show a single peak, helped to substantiate the creation of the copolymers, rather 
than two populations of homopolymers.  
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Scheme 2.1. Synthetic route to poly(DL-lactide-co-2-oxopropylene carbonate) (V) a) trimethyl 
orthoformate, p-toluene sulfonic acid, methanol, 24 h; sodium carbonate, 24 h. b) 
ethylchloroformate, triethylamine, tetrahydrofuran, 3 h c) stannous octoate, vacuum, 130ºC, 1 h. 
d) iodine, acetone, reflux, 2 h. 
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Figure 2.1.  
1
H NMR spectrum of protected poly(lactic acid-co-2,2-dimethoxy-1,3-propylene 
carbonate) (IV) (pLA50-co-DHAC50) in DMSO-d6. 
 
 
  
Molecular Weight (GPC) Protected pLAx-co-DHACy  Deprotected pLAx-co-DHACy  
Mole Feed                   
LA:DHAC 
Confirmed 
Ratio 
LA:DHAC 
Mw (g/mol) Mn (g/mol) Mw/Mn 
Td (ºC) 
50 wt% 
Tg (ºC) 
%        
Deprotected 
Td (ºC)  
50 wt% 
Tg (ºC) 
0:100 0:100 81 000 56 400 1.44 246 45 80 273 68 
15:85 16:84 75 100 ± 700 52 500 ± 1 000 1.43 ± 0.05 240 ± 11 51 ± 1 86 252 ± 1 65 ± 1 
25:75 27:73 62 400 ± 900 45 500 ± 1 900 1.37 ± 0.04 239 ± 1 50 ± 1 90 246 ± 4 64 ± 2 
50:50 52:48 51 400 ± 4 100 35 700 ± 7 200 1.47 ± 0.20 240 ± 4 51 ± 1 >95 261 ± 6 58 ± 1 
75:25 78:22 50 400 ± 3 800 37 800 ± 3 200 1.33 ± 0.03 236 ± 2 53 ± 1 >95 330 ± 3 55 ± 1 
85:15 89:11 47 500 ± 7 100 35 400 ± 6 900 1.35 ± 0.07 228 ± 5 52 ± 1 >95 316 ± 27 54 ± 1 
100:0 100:0 37 900 ± 1 200 26 800 ± 2 700 1.42 ± 0.15 236 ± 5 53 ± 1 - - - 
100:0
a
 100:0 - - - - - - 309 ± 37 53 
a
 This value is based on a pLA100 sample subjected to the acetone/I2 deprotection conditions.  
Table 2.1. Molecular weight and thermal data of pLAx-co-DHACy copolymers. 
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Figure 2.2.  
13
C NMR spectrum of protected poly(lactic acid-co-2,2-dimethoxy-1,3-propylene 
carbonate) (IV) (pLA50-co-DHAC50) in DMSO-d6. The peaks assigned to a’, b’, c’, and d’ are 
peak shifts due to the heterogeneous placement of monomers throughout the backbone, i.e. a 
DHAC next to a LA, or a DHAC next to another DHAC. 
 
2.3.2 Monomer distribution analysis 
To further elucidate the distribution of the monomers in the copolymers, 
13
C NMR was 
employed to first verify the structure, seen in Figure 2.2, and then to determine the monomer 
sequence based on the carbon resonances, which can be seen in Figure 2.3. 
13
C NMR spectra 
provided the means to determine whether the copolymer is random, block, or alternating 
depending on how each monomer interacts with its neighboring species.
51, 61-64
 In the case of a 
statistically random copolymer, 2
3
 triads can be theoretically formed and these can be used to 
understand the molecular architecture of the copolymer. For the DL-lactide (L) and the protected 
DHAC (D) copolymers, the 8 possible triads that can be formed are as follows: LLL, LLD, DLL, 
DLD, LDL, LDD, DDL, and DDD. 
13
C spectra of the homopolymers provided the basis for the LLL 
and DDD homopolymer resonances and thus the position of the subunits throughout the 
backbone. The pLA100 spectrum indicated that the resonance for the central carbonyl carbon in 
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LLL is a trio of peaks that lie between 169.0 ppm and 169.21 ppm. The multiple resonances seen 
for pLA100 were attributed to the creation of a mixture of atactic and isotactic regions along the 
polymer backbone and are due to a number of influencing factors. These factors include, but are 
not limited to, the polymerization kinetics, lactide feed composition, the favoring of meso dyads 
in L,L or D,D dimeric repeat units, extent of conversion, and the possibility of transesterification 
when the reaction conditions have a temperature set point higher than 120 
o
C.
62-65
 The protected 
pDHAC100 spectrum showed the DDD resonance at 153.52 ppm for the carbon associated with its 
carbonate bond. The determination of the two extra shifts associated with the carbonate bond’s 
carbon seen in the copolymer spectra was determined by the gradual superposition of the spectra 
toward the homopolymers as the molar feed ratios changed as shown in Figure 2.3. Using this 
information and preliminary predictive 
13
C NMR modeling software, the new peaks observed 
were assigned to the two XLD triads (LLD, DLD) and two XDL triads (DDL, LDL) with signals 
located at 169.47 ppm and 153.18 ppm, respectively.
66
 This information supports the conclusion 
that the synthesized polymers are random copolymers of the LA and DHAC monomers. 
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Figure 2.3. 
13
C NMR spectra of pDHAC100, pLA15-co-DHAC85, pLA25-co-DHAC75, pLA50-co-
DHAC50, pLA75-co-DHAC25, pLA85-co-DHAC15, and pLA100 in DMSO-d6. The chemical 
structures of the eight possible triads along with their respective carbonyls noted have been 
included. 
 
2.3.3 Copolymer deprotection 
The removal of the dimethoxy acetal group to obtain the final copolymer, (V), was 
conducted utilizing a method different from the one previously reported by our group for the 
protected DHAC derived monomer.
21, 22, 25
 To eliminate the possibility of ester hydrolysis from 
the reaction conditions present in a trifluoroacetic acid:water deprotection, a deprotection 
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catalyzed by molecular iodine in acetone was investigated.
55
 With this method the degree of 
deprotection was directly correlated to the molar ratio of LA and DHAC within the copolymer. 
This relationship was found to be caused by the poor solubility of the deprotected DHAC 
monomer in acetone. At higher concentrations of DHAC in the copolymer (≥50%), the 
deprotection reached a solubility limit prior to complete deprotection. When a significant amount 
of the protected DHAC within the copolymer backbone had been deprotected, the LA and 
remaining protected DHAC were no longer able to keep the copolymer soluble in solution 
leading to its precipitation. The degree of deprotection for these ratios, including pDHAC100, 
ranged from 80% to greater than 95% and was determined via 
1
H NMR. An example of the 
deprotected copolymer 
1
H NMR spectrum is shown in Figure 2.4. Interestingly, it was noticed 
that even though the pLA50-co-DHAC50 ratio copolymers came out of solution prior to the two 
hour time point, their degrees of deprotection were all greater than 95%. In contrast, at lower 
concentrations of DHAC (<50%), all of the copolymers remained soluble in the acetone and the 
degrees of deprotection were all found to be greater than 95%. We anticipate that total 
deprotection was not achieved over this two hour time scale due to the presence of trace amounts 
of water in the acetone which has been reported to affect the rate and degree of deprotection.
55 
 
2.3.4 Thermal analysis 
Thermal analysis of the materials was conducted to characterize the influence of each ratio of 
monomers on the copolymer characteristics. Thermal gravimetric analysis (TGA) revealed that 
protected pDHAC100 had a Td of ~246 
o
C, while LA100 showed a Td of ~237 
o
C. The Td for all of 
the protected copolymers was consistent within this temperature range and the data are presented 
in Table 1. Also shown in Table 2.1 are the Td values for the deprotected copolymers. Upon 
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deprotection, the Td of pDHAC100 was elevated to 273 
o
C and a new trend was observed. As the 
ratio of LA increased within the deprotected copolymers, the observed Td also increased to 
values greater than pLA100. This phenomenon may be attributed to the solubility difference of the 
copolymers with varying pLAx-co-DHACy ratios. Due to the insolubility of the copolymer with 
greater than or equal to 50% DHAC, these copolymers precipitate out of solution upon 
deprotection as a fine powder. In contrast, the copolymers that contain more LA remain soluble 
throughout the deprotection and precipitate in cold ether as a sticky mass. Using pLA100 as a 
control under the same deprotection conditions, elemental analysis found a very small residual 
amount of iodine in all of the deprotected copolymers (<0.1%), which may be the cause for the 
increased Td. 
 
Figure 2.4.  
1
H NMR spectrum of deprotected poly(lactic acid-co-2-oxopropylene carbonate) 
(V) (pLA50-co-DHAC50) in DMSO-d6. (*) denotes residual protected DHAC peaks. 
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Differential scanning calorimetry was conducted to further distinguish the thermal 
characteristics of each copolymer. A glass transition temperature, Tg, was observed for each 
copolymer while a melting temperature, Tm, was not observed for any of the copolymers within 
the set temperature range of -60 ºC to 140 ºC. The lack of a Tm also supports the conclusion that 
the LA in the copolymer backbone has little stereospecificity due to the random distribution of 
the D- and L- chiral carbons from the DL-lactide monomer and the inclusion of DHAC in the 
backbone that may disrupt the configuration of chain segments needed to form the crystalline 
lattice.
67
 As seen in Figure 2.5, the Tg of the protected pDHAC100 was ~45 
o
C, while the Tg of 
pLA100 was ~53 
o
C. All of the Tg values for the protected copolymers were between 49 
o
C and 53 
o
C. However, deprotected pDHAC100 showed an increased Tg at ~68 
o
C. The increase in Tg 
observed for the deprotected DHAC homopolymer was also observed for each deprotected 
copolymer (Figure 2.6). A trend was observed toward an increasing Tg as the DHAC content 
within the copolymers increased as shown in Table 2.1. The trend of an increased Tg as the 
molecular weight increased was expected because of the reported relationship that exists between 
Tg and molecular weight.
68
  
An interesting feature of the pLAx-co-DHACy copolymers is their variable solubility as 
the DHAC content within the copolymers change. Earlier work on DHAC homopolymers 
showed that characterization was a challenge.
21
 The introduction of 50% or more LA monomer 
within the copolymer allowed more facile characterization of the copolymers. Copolymers with 
higher LA monomer ratios were soluble in common organic solvents such as acetone, dimethyl 
sulfoxide, and dichloromethane. This solubility allowed the I2/acetone deprotection method to be 
more reliable than the previously reported TFA-based methods because it avoids potential acid 
catalyzed hydrolysis of the copolymer backbone, which can lead to a reduced molecular weight. 
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Figure 2.5. DSC traces for all protected copolymer ratios. 
 
 
 
Figure 2.6. DSC traces for all deprotected copolymer ratios. 
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2.3.5 In vitro degradation of poly(DL-lactide-co-2-oxopropylene carbonate) 
To begin to evaluate hydrolysis of the copolymer, an eight week in vitro degradation 
study was performed. Due to the physical form of the >50% LA deprotected copolymers when 
precipitated, the pLA75-co-DHAC25 and the pLA85-co-DHAC15 copolymers were unsuitable 
candidates for the degradation study. Following deprotection, the precipitated pLA75-co-DHAC25 
and the pLA85-co-DHAC15 became very tough, solid materials that were not amenable to 
grinding into a powder. However, the ratios of pLAx-co-DHACy with ≤50% LA had a fine 
powdery physical form upon deprotection making them much more suitable for a study of this 
nature. Three copolymers with monomer ratios were synthesized: pLA50-co-DHAC50, pLA25-co-
DHAC75, pLA15-co-DHAC85 by varying the amount of initiator to obtain copolymers with a Mw 
~70 kDa and slightly higher molecular weight distribution of ~1.7-1.8 than the previous 
materials (Table 2.2). Due to the insolubility of the deprotected copolymers in common GPC 
mobile phase solvents, molecular weight values to track the degradation of the copolymer 
backbone vs. time were unable to be obtained. Thermal characterization of these higher 
molecular weight copolymers showed slightly altered values for Td and Tg due to the change in 
molecular weight and polydispersity. The glass transition temperature data observed for the 70 
kDa in vitro degradation copolymers are shown in Table 2.2. The decrease in Tg as compared to 
the Tg  of the copolymers shown in Table 1 is most likely attributed to the increase in the 
polydispersity, where the molecular weight range increases the number of lower molecular 
weight polymers in the final material that can act as plasticizers.
69
 Static contact angle 
measurements revealed that the surface of each copolymer ratio, while tending to be more 
hydrophilic in nature, did not vary significantly among the three different ratios.  
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  Molecular Weight (GPC) Deprotected pLAx-co-DHACy   
Mole Feed                   
LA:DHAC 
Mw (g/mol) Mn (g/mol) Mw/Mn 
contact angle 
(º) 
Td  
(ºC) 
Tg 
 (ºC) 
15:85 69 900 ± 1 200 40 500 ± 3 800 1.77 ± 0.10 60.5 ± 1 233 58 
25:75 71 200 ± 2 400 39 800 ± 2 600 1.79 ± 0.10 61.5 ± 1 234 56 
50:50 70 000 ± 2 300 43 500 ± 2 000 1.66 ± 0.10 61.5 ± 1 260 56 
 
Table 2.2. Molecular weight and thermal data for the copolymers used in the in vitro degradation 
study. The Td is measured at 50 wt%. 
 
Visual inspection of the compressed tablets from each time point, post lyophilization, 
showed a white exterior and cylindrical shape, with each tablet maintaining its geometry and 
color over the course of the erosion study. Upon fracture, the interior was the same white color 
as the exterior and each sample appeared to have uniform structural integrity throughout the 
tablet. This result is significant because monomeric DHAC degrades to DHA, which can further 
degrade into a dark brown product, suggesting chemical degradation past DHA does not occur 
within the pellet. Depending on the copolymer composition, the longer time points of 4 weeks 
and 8 weeks contained samples that were more brittle. However, comparing the interior and 
exterior of each sample, there were no visual signs of any large difference in mechanical 
properties, color changes, or morphology. This result is particularly interesting because a number 
of studies have tracked the in vitro degradation of lactic acid-derived polymers and copolymers 
and have found significant morphological changes over the course of the experiment. To directly 
compare with relevant literature, Li, et al, tracked the degradation of DL-lactic acid based 
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polymer tablets formed using direct compression molding at a temperature below its Tg. They 
observed that amorphous PLA polymers underwent heterogeneous degradation with the rate of 
degradation on the inside faster than that of the outside.
70, 71
 This “inside-out” degradation 
pattern leads to the formation of a hard, white outer shell surrounding a viscous, transparent core 
that could be seen starting at 6 weeks for 100% LA (Mw = 65 000 kDa). Other studies have 
investigated similar morphological changes and the autocatalytic effect that causes these 
polyesters to degrade in this particular pattern.
10, 56, 57, 71
  
Compared to the in vitro degradation of polyesters, specifically LA homopolymers, the in 
vitro degradation of polycarbonates and poly(carbonate-ester)s is quite different. Long term in 
vitro degradation studies using high molecular weight polycarbonate homopolymers derived of 
1,3-trimethylene carbonate (TMC) show no sign of degradation after 2 years (Mn = 320 kDa) , 
while pTMC50-co-LA50 copolymers (Mn = 220 kDa) show mass loss starting around 10 weeks 
with the onset of degradation occurring later with increasing TMC content.
58
 Another study with 
lower molecular weight homopolymers of TMC (Mn = 114 kDa) showed no mass loss during a 
53 week in vitro degradation study, while pTMC67-co-LA33 (Mn = 88 kDa) and pTMC50-co-LA50 
(Mn = 104 kDa) displayed mass loss at 9 weeks.
59
 Both studies exemplify the trend that TMC 
and LA based poly(carbonate-ester)s have an increasing degradation rate with increasing ester 
content in their backbone, opposite of the results with pLAx-co-DHACy copolymers seen in 
Figure 2.7. In general, the poly(carbonate-ester) degradation pattern can be attributed to 
carbonate bonds being less labile to hydrolysis than ester bonds, but for pLAx-co-DHACy 
copolymers we see the opposite.
60
 These results however are consistent with previous reports of 
DHA based polycarbonates.
21, 26
 Also of note is that, unlike copolymers containing only ester 
bonds, studies using other poly(carbonate-ester)s comprised of glycerol and L-lactic acid showed 
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no appreciable change in physical appearance throughout a two week study time period even 
though there was a molecular weight decrease of 35%.
51 
 
2.3.6 Interior visualization  
To further explore the mechanism of degradation, SEM was used to visualize the erosion 
pattern on a microscopic level. Images were taken from the top, side, and cross-sectional 
surfaces to get a better understanding of the copolymer erosion mechanism. The images show 
that those copolymers with more LA in their backbone took longer to erode during the 
experimental time frame than those richer in DHAC. This visual finding correlates to the mass 
loss data seen in Figure 2.7 which also shows that copolymers with more LA in the backbone 
erode at a much slower rate than those with more DHAC in the backbone. The top and side 
views show a similar erosion pattern for the three ratios, though the erosion was much more 
accelerated in pLA15-co-DHAC85 than in pLA50-co-DHAC50 and can be seen in Figure 2.8. 
Similar to the top and side views, upon comparison of the cross-sectional views, a different 
degradation pattern was seen among the three ratios and these results are shown in Figures 2.9 
and 2.10. The materials made of pLA50-co-DHAC50 showed very little morphological change in 
the center of their cores until 4 weeks, whereupon small pores had begun to form. However, the 
edges closest to the outside surfaces of the cross-sectional view appear to erode much more 
rapidly at earlier time points. At the one day time point, subtle morphological changes and small 
pores seem to form near the edge. This area of erosion increased in size with the length of time 
the tablets were allowed to rotate in the buffer solution and by day 56 noticeable regions of 
erosion near the edges can be seen in Figure 2.11, as compared to the relatively unaltered 
interior. Tablets made of pLA25-co-DHAC75 showed a similar erosion pattern to those made of 
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pLA50-co-DHAC50, where the very center of the material did not show signs of degradation until 
the 4 week time point. At this time a change in morphology and pores was once again observed. 
Unlike pLA50-co-DHAC50, the interior edge of pLA25-co-DHAC75 showed a larger, more distinct 
region of erosion and by week 8 the entirety of the material’s cross-section showed 
morphological changes. In comparison, the copolymers comprised of pLA15-co-DHAC85 began 
to show morphological changes to the center of the interior by 2 weeks. These copolymers also 
had the largest eroded region near the edges of the interior as compared to the copolymers 
containing more LA. Also of note is that the pLA15-co-DHAC85 copolymers eroded to 
completion between weeks 6 and 7 and by week 2 the copolymer’s cross-section showed 
morphological changes throughout the tablet.  
These findings indicate that these poly(carbonate-ester)s display both surface and bulk 
erosion patterns that are unlike the erosion patterns seen with other lactic acid or lactic acid 
derived copolymers. The SEM images show that there is an erosion zone near the edges of the 
sample, and the area of this zone increases during later time points. However, at later times 
during the study, the very center of the interior does begin to show morphological changes as 
well. The erosion rate for all three samples does display some linearity, but there is not a 
constant value throughout the study that would indicate that this material erodes by only surface 
erosion. The data also do not indicate that this material erodes only by bulk erosion since the 
geometry of the materials stays consistent and there is no distinct time at which a drastic change 
in erosion rate occurs, a phenomenon normally seen with lactic acid or lactic acid copolymers. 
Li, et al, reported previously that pure DL-lactic acid polymers (Mw=65 kDa) showed this 
extreme rate change at 7 weeks, while for the pLA50-co-DHAC50 copolymer there is no extreme 
change of erosion rate throughout the 8 week study.
70, 71
 This result is surprising since extensive 
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work by the Göpferich group to model erosion behavior shows that there is a critical thickness 
required before a sample can undergo surface erosion.
28, 29
 This thickness has been theorized to 
be 7.4 cm for poly(α-hydroxy-acids). Other studies that track the erosion of TMC and LA 
poly(carbonate-ester)s reported a shift from surface erosion to bulk erosion with a LA content of 
more than 30% in the backbone.
60
  
 
 
 
Figure 2.7. Mass loss as a function of degradation time for LA and DHAC copolymers: (♦) 
pLA50-co-DHAC50 (■) pLA25-co-DHAC75 (●) pLA15-co-DHAC85  
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Figure 2.8. SEM of the top surface of pLAx-co-DHACy copolymers taken at select time points 
(magnification = 5000 x). The shaded region of the image in the bottom right depicts the surface 
that is under magnification. The day 56 image for pLA15-co-DHAC85 does not exist due to 
complete degradation prior to this time point. 
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Figure 2.9. SEM of the cross-sectional surface near the interior of LAx-co-DHACy copolymers 
taken at select time points (magnification = 5000 x). The shaded region of the image in the 
bottom right depicts the surface that is under magnification. The day 56 image for pLA15-co-
DHAC85 does not exist due to complete degradation prior to this time point. 
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Figure 2.10. SEM of the cross-sectional surface at the edge of pLAx-co-DHACy copolymers 
taken at select time points (magnification = 1000 x, tilt = 61º). The shaded region of the image in 
the bottom right depicts the surface that is under magnification. The day 56 image for pLA15-co-
DHAC85 does not exist due to complete degradation prior to this time point. 
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Figure 2.11. SEM of the entire cross-sectional surface of pLA50-co-DHAC50 copolymer taken at 
56 days (magnification = 315 x).  
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2.4 Conclusion 
Random copolymers of cyclic DL-lactide and a 6-membered ring of carbonyl-protected 
dihydroxyacetone carbonate can be synthesized via a ring-opening polymerization. The 
chemically protected DHAC subunits of the copolymer were deprotected with a new method 
using elemental iodine in acetone. By successfully employing this new deprotection scheme, 
future DHA based polymers can be reliably created in a more favorable environment (i.e less 
hydrolysis) than previously studied.
21
 It was found that by copolymerizing DHAC with a 
monomer of higher solubility in common solvents, a better degree of deprotection could be 
achieved. The intrinsic characteristics of each molar ratio of the LA and DHAC copolymers 
revealed degradation temperatures and glass transition temperatures above physiological 
temperature. The copolymer also showed unique degradation and erosion characteristics. It was 
found that even with LA amounts of 50% within the copolymer backbone there appeared to be a 
more surface like erosion pattern. It was also observed that contrary to previously reported 
polycarbonate behavior, increasing the amount of polycarbonate content within the copolymer 
increased the rate of degradation by hydrolysis. These poly(carbonate-ester)s possess very 
unique and favorable intrinsic characteristics such as the apparent lack of a viscous core 
formation due to lactic acid build up in the interior of the pellet, or the increased degradation rate 
with copolymers more rich in carbonate bonds.  
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CHAPTER 3 – DEVELOPING A NEW METHOD FOR POLY(CARBONATE-ESTER) 
DEGRADATION ANALYSIS 
 
 
 
 
 
 
 
 
 
 
 
Reprinted from Analytical Biochemistry, 430(2), Jennifer R. Weiser, Nicole G. Ricapito, Alice 
Yueh, Ellen L. Weiser, David Putnam, A mechanistic analysis of the quantitation of α-hydroxy 
ketones by the bicinchoninic acid assay, 116-122., Copyright (2012), with permission from 
Elsevier. 
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3.1 Introduction 
The bicinchoninic acid (BCA) assay, originally developed as a way to quantify the 
concentration of reducing sugars, is widely used as a powerful tool for protein quantification.
72-76
 
The BCA assay determines the total concentration of an analyte through the reduction of Cu
2+
 
ions under alkaline conditions. This reduction event generates Cu
1+
 which reacts with 
bicinchoninic acid to form a complex that absorbs light strongly at 562 nm.
31, 32
 The absorbance 
of this complex is then used to quantify an analyte’s concentration either using Beer’s law 
(A=*b*c) or according to a standard curve.  
However, while the BCA assay is robust, a number of compounds interfere with it.
77-81
 In 
the past few decades, a considerable number of compounds have been identified that can 
complicate the quantitation of specific analytes. The instructions of the most common BCA 
protein assay kit, produced by a number of manufacturers, acknowledge the potential of false 
readings from a number of compounds that can interfere with the assay. These include, but are 
not limited to, mercaptoethanol, phospholipids, hydrogen peroxide and sulfo-N-
hydroxysuccinimide, all of which give erroneously high absorption readings.
77-81
 Other 
compounds, such as ammonium sulfate and 2-D-pharmalyte, reduce the amount of color the 
BCA assay can produce, thereby leading to erroneously low absorption readings.
77
 More recently 
the assay was used to determine sulfhydryl, N-hydroxysuccinimido carboxylate, aldehyde, and 
hydrazide functional groups on a variety of solid supports.
82
 
Recently, we found that compounds from a previously unreported structure class, 
specifically the -hydroxy ketone structure, influence the accuracy of the BCA assay to give 
erroneously high absorbance readings. The -hydroxy ketone class of compounds is susceptible 
to autoxidation, and can enolize via an enediol intermediate during tautomerization.
83, 84
 These α-
48 
 
hydroxy ketone compounds also can undergo tauromerization in the same manner as reducing 
sugars.
84, 85
 Under alkaline conditions, such as those found in the BCA assay (pH 11.25), 
reducing sugars isomerize to an equilibrium mixture of aldoses and ketoses via the same enediol 
intermediate.
86, 87
 However, the α-hydroxy ketone class of compounds is far more effective at 
reducing the copper than reducing sugars, which causes a very strong absorbance reading in the 
BCA assay. We therefore hypothesized that the ability of α-hydroxy ketones, and by extension 
reducing sugars, to form an enediol intermediate is the mechanism through which these 
compounds are amenable to quantitation by the BCA assay. The ability of these chemicals to 
reduce Cu
+2
 and affect the BCA assay provides a very useful tool in quantifying these 
compounds. It is also important to note that if an α-hydroxy ketone is present in a sample, it may 
interfere with the accuracy of the results when conducting the BCA assay on solutions that 
contain other analytes, such as proteins. However, the ability of these chemicals to reduce Cu
+2
 
and affect the BCA assay provides a very useful tool in quantifying α-hydroxy ketone 
compounds. By harnessing the BCA assay, there is now a tool able to track the degrading 
polymer backbone of dihydroxyacetone based polymers that are otherwise unable to be 
characterized using more common methods, such as GPC.  
 
3.2 Experimental  
3.2.1 Materials 
1,3-Dihydroxyacetone dimer, dihydroxyacetone phosphate hemimagnesium salt hydrate, 
dextrose, fructose, DL-glyceraldehyde dimer, p-toluene sulfonic acid, bovine serum albumin 
(BSA), Bradford reagent, ninhydrin reagent and 2,2-dihydroxyindane-1,3-dione were purchased 
from Sigma-Aldrich (St. Louis, MO) and used as received. Acetoin, acetone, ethyl alcohol, ethyl 
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acetate, glycerol, triethyl orthoformate, sodium carbonate (Na2CO3), 0.1N silver nitrate, 28% 
w/w aqueous solution of ammonia, and 0.1N NaOH were purchased from VWR (West Chester, 
PA) and used as received. 1,5-Dihydroxypentan-3-one was purchased from Santa Cruz 
Biotechnology
®
, Inc. (Santa Cruz, CA) and used as received. Phosphate buffered saline (10.0 M, 
PBS) without calcium or magnesium was purchased from BioWhittaker
®
 (Lancaster, MA) and 
diluted to 1.0 M with 18 Ω water. Corning® Costar® brand, clear, 96-well cell culture plates were 
purchased from Fisher (catalog number 3599). BCA Protein Assay kit (product number 23225) 
was purchased from Thermo Fisher Scientific, Inc.  
 
3.2.2 Synthesis of (2,5-diethoxy-1,4-dioxane-2,5-dimethanol)  
The protected 1,3-dihydroxyacetone (DHA) dimer was synthesized using a previously 
reported method.
25
 A 500 mg round bottom flask was charged with dihydroxyacetone dimer (32 
g, 177.8 mmol), triethyl orthoformate (60 mL, 360 mmol), and p-toluenesulfonic acid (128 mg) 
in 300 mL of ethyl alcohol. The mixture was stirred for 24 h, after which time 400 mg of 
Na2CO3 was added. The reaction mixture was stirred for an additional 30 min before filtration. 
The solvent and residual triethyl orthoformate were removed in vacuo and the product 
recrystallized from ethyl acetate to yield the title compound (31 g, 74%). 
1
H NMR (CDCl3) δ: 
1.23-1.26 (6H), 3.53-3.95 (12H). Anal. Calcd: C, 50.85; H, 8.47. Found: C, 51.14; H, 8.70. 
 
3.2.3 BCA assay 
Various concentrations, ranging from 1.11x10
-2 
M to 1.72x10
-4
 M, were selected for each 
compound. All serial dilutions were done with 1X PBS buffer. The assay was run under standard 
conditions according to the manufacturer’s directions, 50:1 bicinchoninic acid and tartrate in an 
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alkaline carbonate buffer (reagent A) to 4% copper sulfate pentahydrate solution (reagent B), and 
the relative intensity of the reading determined at 562 nm on a SpectraMAX Plus384 Microplate 
Reader (Molecular Devices Corporation) after an hour incubation at 37 °C.  
 
3.2.4 Copper(II) ion ratios in the BCA assay working reagent  
A standard curve for DHA with concentrations ranging from 4.44x10
-2
 M to 6.94x10
-4 
M 
was created in triplicate. All serial dilutions were done with 1X PBS buffer. The BCA assay 
solution was then prepared six times varying the copper concentration by changing the 
conditions of reagent B while holding the volume of reagent A fixed. The DHA samples were 
allowed to incubate for one hour at 37 °C with the various BCA working reagent conditions 
before the absorbance was read. Due to the saturation of the signal, each sample was diluted 10X 
post incubation, or in the case of the 4.4x10
-2 
M, 20X, and the relative percent absorbance as 
compared to the largest signal of 4.44x10
-2
 M DHA in a 50:3 working reagent ratio was 
determined.  
 
3.2.5 Protein sample interference  
A standard curve for BSA with six concentrations ranging from 0.5 mg/ml to 1.56x10
-2
 
mg/ml and a standard curve for DHA with four concentrations ranging from 0.125 mg/ml to 
1.56x10
-2
 mg/ml (1.38x10
-3
 M to 1.72x10
-4
 M) were created in triplicate. All serial dilutions 
were made with 1X PBS buffer. To each interference trial, the BSA concentration was varied 
while a constant amount of DHA was added to each sample. This was repeated four times so that 
each concentration of DHA was added to the entire range of BSA concentrations. The mixed 
BSA and DHA samples were the run in the BCA assay in triplicate using the same conditions 
listed previously.  
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3.2.6 Bradford assay 
A serial dilution for DHA with concentrations ranging from 1.11x10
-2 
M to 1.72x10
-4
 M 
was created in triplicate using 1X PBS buffer. The assay was run under the standard conditions 
as recommended by the supplier’s instructions.  
 
3.2.7 Ammoniacal silver nitrate (Tollen’s reagent) 
In a 20 mL glass vial was charged 150 mg of the α-hydroxy ketone based analyte in 1 mL 
18 Ω water. To this was added 7.5 mL of 0.1N silver nitrate and 15 mL of 28% w/w solution of 
aqueous ammonia hydroxide. The vial was then rotated by hand continuously for approximately 
five minutes at room temperature until a silver mirror or finely divided black precipitate formed. 
 
3.2.8 Ninhydrin protein assay 
As per the assay guidelines from Sigma-Aldrich, a 50 μM solution of sample (DHA or 
glycine) was prepared in 0.05% glacial acetic acid. A 2 mL aliquot was added to a glass test tube 
to which 1 mL of ninhydrin reagent (2% solution of ninhydrin and hydrindantin in dimethyl 
sulfoxide and lithium acetate buffer, pH 5.2) was added. The test tubes were then allowed to sit 
in boiling water for 10 minutes before cooling to room temperature and the subsequent addition 
of 5 mL of 95% ethanol. Then 200 μl of each solution was then put in a 96 well plate and the 
absorbance determined at 570 nm. 
 
3.2.9 Ninhydrin enediol test 
In a 20 mL vial was charged equimolar amounts (1.0 mol) of 2,2-dihydroxyindane-1,3-
dione (ninhydrin) and the α-hydroxy ketone compound DHA or DL-glyceraldehyde. To this was 
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added 10 mL of either 1X PBS, 18 Ω water, 0.1N NaOH or reagent A from the BCA assay kit. A 
1mL aliquot was taken from each mixture and placed in a separate tube. To this was added 20 μL 
of reagent B and the solution thoroughly mixed at room temperature for 30 seconds. The tubes 
were then centrifuged for 1 minute at 3000 rpm to collect any precipitate. The precipitate was 
then recrystallized in acetone and dried in vacuo. 
1
H NMR (DMSO-d6) δ: 6.48 (s; 2H, OH), and 
7.97 (s; 8H, aromatic H) 
 
3.3 Results and Discussion 
3.3.1 The role of structural arrangement of the analyte in the BCA assay 
To highlight the impact α-hydroxy ketones have on the BCA assay, a variety of 
compounds either containing the α-hydroxy ketone arrangement, or lacking this arrangement, 
were subjected to the BCA assay. Using a consistent molar basis for the study and a number of 
compounds with similar structures, the percent reactivity, relative to DHA, were determined 
(Figure 3.1). Figure 3.1 shows that 1,3-dihydroxypropan-2-one, more commonly referred to as 
dihydroxyacetone (DHA), has the strongest response to the assay and was designated at 100%. 
DHA, which exists in equilibrium with its dimeric form in solution, has an extremely sensitive 
response to the BCA assay reagents. It produces a 30 times more sensitive response than glucose, 
a reducing sugar. DHA is also known to tautormerize readily to glyceraldehyde under alkaline 
conditions, which are the conditions present in the BCA assay (pH 11.25).
88-91
 To support the 
hypothesis that the BCA assay is affected positively by the enol-diol tautomer formed by α-
hydroxy ketones, and to put forward that this intermediate may be co-ordinating metal ions, 
structural analogs of DHA were investigated at equivalent concentrations. 
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Figure 3.1. Percent reactivity of assayed compounds relative to 1,3-dihydroxyacetone dimer in 
the BCA assay on a molar basis of 2.75x10
-3 
M showing the strong response α-hydroxy ketones 
have within the assay. 
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The first derivative explored was a locked form of the DHA dimer, 2,5-diethoxy-1,4-
dioxane-2,5-dimethanol, to determine whether the monomeric DHA or the dimeric form led to  
the signal in the BCA assay. This compound showed no response in the BCA assay, maintaining 
the posit that it is the monomeric DHA’s ability to form the enediol tautomer that causes a 
response to the assay. To explore the significance of the α-hydroxy ketone structure, another 
variation of DHA, 1,5-dihydroxy-pentan-3-one, was tested. While it contains both hydroxyl 
groups and a ketone group, this structure has a β-hydroxy ketone arrangement. This compound 
showed no response to the assay and suggests that the proximity of the hydroxyl groups to the 
carbonyl is a structural necessity to reduce the Cu
2+
.  
To further show the significance of the α-hydroxy ketone structural arrangement, the 
simplest variation on DHA’s structure, the common solvent acetone, was evaluated. Acetone 
lacks the hydroxyl groups, but does have the ketone group at the C2 position. Acetone showed 
no response to the assay under the same conditions as the previous compounds, again 
highlighting the importance of the proximity of a hydroxyl group. A final example that showed 
the relevance of the α-hydroxy ketone structure and the importance of its ability to enolize, is 
glycerol. Glycerol, a trihydric alcohol, does not possess a carbonyl and thus gave no response to 
the BCA assay. These data exemplify that it is not just the proximity of the two alcohol groups 
formed during enolization that may co-ordinate the copper, but that the movement of electrons 
during tautomerization causes a change in the metal ion’s energy state.  
Another variation of DHA that also exemplifies the structural arrangement of the 
hydroxyl groups to a keto group is acetoin. As expected, this simple compound with an α-
hydroxy keto structure, does give a positive response in the BCA assay. This response, while 
weaker than that of DHA, is strong in comparison to that of non-ketone α-hydroxy reducing 
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sugars. A final derivative of DHA tested, dihydroxyacetone phosphate, showed about a 6-7 fold 
decrease in sensitivity to the assay compared to DHA, but still gave a remarkably strong signal. 
This weaker response may be attributed to the phosphate group’s hindrance to the enediol 
tautomer formation.  
One other unique α-hydroxy ketone that also was tested in the BCA assay and gave a 
characteristic response was fructose. Fructose, a reducing sugar, contains the α-hydroxy ketone 
backbone arrangement, unlike the majority of other common reducing sugars. Fructose is known 
to be one of the most sensitive of the reducing sugars in the BCA assay and this increased 
sensitivity was seen when compared with glucose in Figure 3.1.
73, 74, 92
 The increased sensitivity 
to the assay may be correlated to the manner in which the enediol intermediate is formed. Like 
other α-hydroxy ketones, fructose has the ability to form a diketone intermediate with the C2 and 
C3 carbon as well as a ketoaldehyde intermediate between the C1 and C2 carbons, while other 
reducing sugars, such as glucose and galactose, form only the ketoaldehyde intermediate. 
87, 93, 94
 
This diketone intermediate may attribute to why fructose gives a much stronger response than the 
other sugars in the BCA assay.  
 
3.3.2 Copper(II) ion ratios in the working reagent of the BCA assay  
As per the Thermo Fisher Scientific, Inc., Pierce
®
 BCA Protein Assay Kit suggestions, 
copper concentrations in the working reagent are varied to study the affect of copper chelation 
versus copper reduction. As seen in Figure 3.2, there is a linear correlation in relative percent 
absorbance as the DHA and copper(II) ion were varied. This correlation indicates that the 
mechanism by which α-hydroxy ketones influence the assay is not by a copper chelating affect, 
but a reduction of the Cu
2+
 to Cu
1+
.
80
 In the standard working reagent ratio, 50:1 (reagent A:B), 
the DHA response is limited by the amount of copper present for the two highest DHA 
56 
 
concentrations reported (4.44x10
-2
 M and 2.22x10
-2
 M). This trend is more pronounced as the 
amount of reagent B (the copper) in the working ratio is decreased and it is apparent that this is 
the limiting reagent for the majority of the DHA concentrations as evidenced by the signal 
plateau. Conversely, as the copper ratio in the working reagent increases, (an increase in reagent 
B), the DHA becomes the limiting reagent in the BCA assay, which leads to the signal plateau in 
the more concentrated DHA samples. This relationship is best represented by observing that 
higher concentrations of DHA still give a stronger relative percent absorbance than the DHA 
concentration that has a signal plateau. This direct proportionality supports the purported 
mechanism of direct cupric ion reduction by this class of analytes.  
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Figure 3.2. Relative percent absorbance readings for various concentrations of DHA (4.44x10
-2
 
M to 6.94x10
-4 
M) and amounts of copper (reagent B) in the BCA assay working reagent as 
compared to 4.44x10
-2
 M DHA in a 50:3 working reagent ratio. Standard working reagent 
conditions are 50:1 (reagent A to reagent B).  
 
3.3.3 Analyte interference of protein quantitation in the BCA assay 
To exemplify how an α-hydroxy ketone may interfere with protein quantitation, an array 
of DHA samples were added to standard curves created using the model protein, bovine serum 
albumin (BSA). The results of this experiment are shown in Figure 3.3. Over the entire range of 
concentrations, a direct relationship exists between the absorbance value obtained and the 
amount of α-hydroxy ketone added to the protein sample. Seen in Figure 3.4, the effect on the 
final absorbance values by adding DHA to BSA is consistent and additive. Calculating the 
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theoretical absorbance value by adding a BSA absorbance at a set concentration with a DHA 
absorbance at a set concentration yield values that are comparable to the experimental value 
obtained when combining these compounds prior to running the BCA assay. These results show 
the interference various concentrations of an α-hydroxy ketone can have on a protein sample. 
However, due to the additive nature of this effect, if the concentration of α-hydroxy ketone is 
known, then the concentration of the protein is quantifiable using the BCA assay.  
 
3.3.4 The response of α-hydroxy ketones to the Bradford assay  
To further support the unique quantification of α-hydroxy ketones in the BCA assay, 
other standard protein assays were investigated. The Bradford assay, based on the Coomassie 
Brilliant Blue G-250, run under acidic conditions, follows the conversion of a red form of the 
dye to a blue form at 595 nm.
95
 This assay showed no colorimetric response to our model α-
hydroxy ketone, DHA.  
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Figure 3.3. Absorbance readings for various concentrations BSA and DHA in the BCA protein 
assay. These values show the magnitude of interference an α-hydroxy ketone contaminate has on 
protein samples. 
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Figure 3.4. The colorimetric response at 562 nm in the BCA assay between BSA absorbance 
(ABSA = 0.125 mg/ml or 0.25 mg/ml) added to DHA absorbance (ADHA = 1.72x10
-3
 M), yielding 
a theoretical additive absorbance in comparison to the experimental absorbance obtained. The 
correlation between the theoretical and the experiment values show the consistent and additive 
affect to the absorbance reading an α-hydroxy ketone sample has when mixed with a protein 
sample. 
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3.3.5 The response of α-hydroxy ketones to Tollen’s reagent 
To confirm α-hydroxy ketone’s ability to form enediol intermediates under BCA assay 
conditions, the ammoniacal silver nitrate reaction (Tollen’s reagent) was performed. Tollen’s  
reagent is typically used to differentiate between aldehydes and ketones, but in the case of α-
hydroxy ketones, a positive response is also observed. The Tollen’s reagent is run in similar 
conditions to the BCA assay, where the pH is basic (approximately 10) and the final response is 
a reduction of Ag
1+
 (aq) to Ag
0
 (s). Both DHA and glyceraldehyde formed the classic silver 
mirror coating on glass indicative of a positive result for the formation of an enediol intermediate 
(Figure 3.5). In the case of dihydroxyacetone phosphate (DHAP), a finely divided black 
precipitate was formed. The mechanism of action through which Tollen’s reagent interacts with 
α-hydroxy ketones involves the formation of an enediol intermediate, which leads to silver 
reduction. These responses further support the implication of the enediol formation in the BCA 
assay.
96
  
 
 
                Glyceraldehyde            Dihydroxyacetone 
 
Figure 3.5. Result of the Tollen’s reagent silver mirror test on glyceraldehyde and DHA. 
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      A         B            C               D 
 
Figure 3.6. Result of adding ninhydrin to DHA and reagent A of the BCA assay. (A) DHA in 
deionized water. (B) Ninhydrin in deionized water. (C) Ninhydrin in Reagent A (main 
component is 0.1 N NaOH). (D) Equimolar amounts of DHA and ninhydrin in Reagent A.  
 
3.3.6 The response of α-hydroxy ketones to ninhydrin 
To experimentally confirm the purported mechanism through which α-hydroxy ketones 
interact with the BCA assay, ninhydrin was utilized. The classic ninhydrin test for proteins did 
not show the formation of Rhuemann’s purple for α-hydroxy ketones, a response typically 
observed when working with compounds containing ammonia and/or primary and secondary 
amines. A glycine control developed an expected strong color that was sensitive at 570 nm, 
however DHA solutions made with 0.05% glacial acetic acid or a DHA solution of 1.11x10
-2 
M 
in 1X PBS buffer turned light red upon heating(Figure 3.6). This result is significant because the 
red color is associated with ninhydrin being reduced to a monovalent anion, indanone-enediol 
structure. As the reduction of ninhydrin proceeds, a crystalline precipitate of hydrindantin 
forms.
96-99
 This response is more strongly observed in dilute basic conditions, when solid 
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ninhydrin is combined with a compound that can form an enediol. Under these conditions, the 
ninhydrin is reduced while the other compound is oxidized via its enediol pathway. This 
precipitate was observed when equimolar amounts of DHA and ninhydrin were combined in 
only reagent A of the BCA assay or in 0.1N NaOH, the major component of reagent A, after a 24 
hour time period. A 
1
H NMR taken of the precipitate, Figure 3.7, correlates with known 
1
H NMR 
spectra of hydrindantin.
100
 No precipitate formed and there was no color change when the 
ninhydrin and DHA were placed in water or PBS over the course of 48 hours. Also of note is 
that, while aldehydes do react in the BCA assay as previously explored by Tyllianakis, et al., 
they do not react with ninhydrin in the same manner as α-hydroxy ketones.82 The addition of 
propionaldehyde to ninhydrin in either reagent A or 0.1N NaOH saw no color shift to red or 
formation of a precipitate. From these observations we conclude that the mechanism through 
which aldehydes produce a colormetric response to the BCA assay is not the same mechanism 
through which α-hydroxy ketones elicit a colorimetric response.  
The hydrindantin precipitate was observed to form much more rapidly when all of the 
BCA assay conditions were present. It was seen that ninhydrin alone in reagent A or in 0.1N 
NaOH was a yellow color, while DHA alone in either solvent was colorless. (Figure 3.6) 
However, when both ninhydrin and DHA were dissolved in either reagent A or 0.1N NaOH, the 
solution turned a deep red color. The red color was attributed to the oxidation of the α-hydroxy 
ketone’s enediol intermediate in the basic conditions, while the ninhydrin was reduced. When the 
solutions are allowed to sit at room temperature for 24 hours, a precipitate of hydrindantin 
formed, a result that is in agreement with previous work using ascorbic acid and ninhydrin. 
97-99
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Figure 3.7. 
1
H NMR spectrum of the hydrindantin precipitate in DMSO-d6. 
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Upon addition of reagent B (the copper) to the solution of DHA and ninhydrin in reagent 
A, the deep red color shifted to a deep purple color along with the rapid formation of a 
precipitate. This purple color is likely in response to the Cu
2+
 reducing to Cu
1+
, which then 
complexes with the bicinchoninic acid. The precipitate formed in the presence of both the 
ninhydrin and another α-hydroxy ketone is that of hydrindantin.97, 98. Conversely, adding reagent 
B to the deep red colored solution of DHA and ninhydrin in 0.1N NaOH, there was an immediate 
change of color to pale blue along with the precipitate. This response is a better way to visualize 
how the BCA assay is sensitive to enediol formation. The loss of the red color as the copper ion 
is added is likely a result of the indanone-enediol reoxidation as the copper is reduced. The 
subsequent addition of bicinchoninic acid to this solution via the addition of reagent A, yields the 
usual BCA assay color response as seen with an immediate shift in color to deep purple. These 
experiments were conducted in parallel with DL-glyceraldehyde as the model α-hydroxy ketone, 
and the results were the same as DHA. These responses confirm the proposed mechanism where 
the DHA and other α-hydroxy ketones need to form the enediol to proceed with the positive 
response in the BCA assay.  
Further support for the enediol mechanism is that ninhydrin itself has an α-hydroxy 
ketone structure. When the solid form of ninhydrin is added to the BCA assay under the same 
conditions as the previously tested compounds, the assay gives a very strong purple colorimetric 
response similar to all the other α-hydroxy ketone compounds tested. No precipitate formed, a 
response only seen with the presence of another enediol in the solution. However, upon addition 
of the BCA assay working reagent, the color of the solution turned red before the deep purple 
color typical of the BCA assay began to develop. The initial appearance of the red color is 
indicative of ninhydrin forming an indanone-enediol and reinforces the proposed enediol 
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intermediate mechanism for the behavior of α-hydroxy ketones in the BCA assay.97, 98 
 
3.3.7  Proposed mechanism of analyte interaction in the BCA assay  
The proposed mechanism of how α-hydroxy ketones react in the BCA assay, shown in 
Scheme 3.1, is hypothesized given our results. We based this scheme on previously reported 
work by others using a copper oxidation system and have extended this correlation through our 
experiments to include the BCA assay system. Studies conducted by Marshall and Waters, 
Thornalley, and Singh focused on the creation of an enediol intermediate which directly 
correlated to a redox event involving metal ions, such as copper.
83-85, 101, 102
 In some of the 
earliest studies, Marshall and Waters noticed that the enolization of α-hydroxy ketones occurred 
naturally to form enediol intermediates. These studies also found that when copper ions were 
present, they were reduced and formed complexes with the enediol radicals.  
Other work by Thornalley explored the autoxidation of the α-hydroxy ketone, DL-
glyceraldehyde under physiological conditions. To understand the mechanism of this oxidation 
event, an important iron porphyrin protein, cytochrome c, was monitored as it was reduced from 
the ferric state (+3) to the ferrous state (+2).
103
 It was seen that a direct correlation existed 
between the DL-glyceraldehyde’s uptake of iodine and the temperature dependence of the rate of 
ferricytochrome c reduction by DL-glyceraldehyde.
84
 This uptake of iodine by α-hydroxy ketones 
is a typical response in the formation of the enediol tautomer, thus helping to link the reduction 
of the iron ion with the enediol intermediate.
104
 In further studies, the formation of the α-
ketoaldehyde enediol intermediate for glyceraldehyde and dihydroxyacetone, 
hydroxypyruvaldehyde, was monitored and shown to be directly related to the autoxidation 
event.
83
 Also of note is the chemical synthesis of hydroxypyruvaldehyde used for components of 
Thornalley’s study. The synthesis of this α-ketoaldehyde occurred via a modified version of a 
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scheme previously derived by oxidizing dihydroxyacetone in the presence of cupric acetate.
105
  
Thornalley’s work also made two other important correlations. The first was at high pH 
there is evidence for deprotonation of the enediol intermediate, which aligns with the conditions 
present in the BCA assay. The second was that enediol anion and enediol oxy radicals that form 
become metal ion coordinated, another finding in agreement with the hypothesized mechanism 
shown in Scheme 3.1. 
 Another study that supports the hypothesized mechanism of how α-hydroxy ketones 
enolize was conducted by Singh.
85
 This group observed that the rate of autocatalysis of 
enolization increases at higher temperatures, which are the conditions found in the standard BCA 
assay. These studies provide mechanistic insight as to how reducing sugars and α-hydroxy 
ketones are quantified by the BCA assay. 
Extensive work done by Richard, again supports the hypothesized mechanism purported 
for the conditions found in the BCA assay. Early work by Richard examined the enediol 
intermediate mechanism in which glyceraldehyde phosphate converts to dihydroxyacetone 
phosphate (DHAP).
106
 Further studies working with DHAP and DHA also show the formation of 
this enediol intermediate when working in a variety of conditions such as higher pH or in the 
presence of metal cations.
107-109
 
The final confirmation for this enediol intermediate is the response seen in the presence 
of ninhydrin. The observation of the red color due to the presence of an indanone-enediol and the 
subsequent precipitation of hydrindantin when other enediol forming α-hydroxy ketone 
compounds are present, enables a correlation to be made to the proposed mechanism. In keeping 
with the results seen by Marshall and Waters, Thornalley, Singh, and Richard, enediol formation 
is an important intermediate in the oxidation activity of α-hydroxy ketones in the BCA assay.  
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Scheme 3.1. Proposed mechanism for an enediol intermediate from α-hydroxy ketones 
responsible for the oxidation of copper in the BCA assay. Adapted from work by Marshall and 
Waters, Singh, and Thornalley. 
83-85, 101, 102
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3.4 Conclusion 
The BCA assay is a tool commonly used for the quantification of proteins. However, new 
explorations into the fundamentals of the assay show that it is a useful tool for quantifying α-
hydroxy ketones. We propose that the ability of these compounds to reduce the copper present in 
the BCA assay is derived in the similar manner in which reducing sugars behave in the assay. 
Both these classes of compounds can undergo enolization, creating an enediol intermediate. This 
process may lead to a co-ordination event that reduces the copper ions, thereby allowing the 
bicinchoninic acid to chelate to the Cu
1+ 
and produce a significant and measurable colorimetric 
response. It must also be taken into consideration that if working with solutions where α-hydroxy 
ketones may be present, elevated readings may result that could interfere with final concentration 
determinations.  
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CHAPTER 4 – CONTROLLED PROTEIN RELEASE FROM DIHYDROXYACETONE 
BASED POLY(CARBONATE-ESTER)S 
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4.1 Introduction 
The ability to control the release of therapeutics using polymer matrices is an important 
factor when designing new drug delivery systems.
10, 56, 110-112
The optimization of polymeric and 
copolymeric based biomaterials is important to successfully create a system that allow for a long-
term, controlled release of therapeutics integrated into a polymer matrix.
113, 114
 The delivery 
criterion of the therapeutic, specifically those that are protein based, will ultimately dictate the 
manner in which the polymeric material’s characteristics are manipulated to influence its 
intended target. The criteria for release from biodegradable polymers include: high polymer 
purity and reproducibility, the mechanism by which the polymeric material degrades (i.e. 
hydrolytic vs. enzymatic), a well-defined release rate of degradation products that are non-toxic, 
and a predictable drug-release profile.
34, 57, 110, 113, 115
 To ensure reliable, long term release of a 
protein, as well as to maintain its biological activity, biodegradable polymer matrices have been 
developed to facilitate a controlled diffusion of the active agent.
10, 113, 116, 117
  
Early work on polymer matrices for controlled drug delivery focused on poly(α-ester) 
systems, specifically poly(α-hydroxy acid)s, such as those based on lactic acid and glycolic 
acid.
10, 110, 115
 Originally, these polymer systems were designed to deliver low molecular weight 
compounds through the hydrolytic degradation of the polymer matrix.
10, 113
 Slow diffusion of the 
compounds and non zero-order release kinetics due to the bulk degradation of the polymers make 
this type of polymer system poorly suited for the release of more fragile compounds, such as 
proteins.
10, 56, 110, 116
 Additionally, the hydrolytic degradation of the polymer occurs via the 
random scission of the ester backbone which leads to bulk erosion and produces degradation 
products that ultimately affect the stability of the encapsulated drug or protein.
56, 57, 110, 116, 118, 119
 
For example, polyesters based on lactic acid can produce very low pH environments due to the 
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build up of the acidic end groups of the monomers.
30, 70, 71
 The acidic monomers follow the same 
diffusion principles as the therapeutic being released, which translates to a slow diffusion out of 
the polymer matrix. The overall effect of this degradation pattern leads to a liquid core, 
surrounded by a hard “shell” and the potential degradation of the therapeutic inside the acidic 
environment. 
30, 70, 71, 118
  
Further exploration of polyester systems for long-term protein release focused on creating 
surface erodible biomaterials by manipulating the polymer main chain composition, such as 
synthesizing polyorthesters or by copolymerizing with other compounds.
57, 58, 60, 110, 116, 120-122
 The 
surface degradation characteristics of a polycarbonate based on 1,3-trimethylene carbonate were 
previously reported, but the degradation of the polymer matrix was relatively slow.
123
 Later work 
explored the creation of copolymers derived from DL-lactic acid and 1,3-trimethylene carbonate 
to produce a highly hydrophobic, surface eroding polymer with an increased rate of 
degradation.
58, 123, 124
 The intent was to use the low water permeability, and subsequent high 
hydrophobicity, of the copolymer to allow for a solid form of a protein integrated into the 
polymer matrix to maintain its biological activity.  
Based on the above principles and our previous study of poly(carbonate-ester) 
copolymers derived from the two naturally occurring biomolecules, lactic acid (LA) and a 
carbonate form of dihydroxyacetone (DHA), the protein release characteristics for these 
copolymers were explored.
125
 The poly(carbonate-ester)’s unique in vitro degradation pattern, 
wherein the carbonate bond appears to be more labile than the ester bond, a phenomenon not 
typically seen, appeared to allow the material to degrade more via surface erosion than bulk 
degradation.
58-60
 This manner of degradation should translate to a system that remains at a more 
stable internal matrix pH, a key aspect during the optimization of a system for the controlled 
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release of a protein based therapeutic.
10, 57, 71, 117, 126
 Furthermore, the degradation products of 
dihydroxyacetone carbonate (DHAC)-based polymers were studied previously and found to 
ultimately degrade into CO2 from the carbonate bond and DHA, materials that are biocompatible 
within the human body.
22-24
 Similarly, the degradation products of LA-based polymers are well 
characterized and are known to be biocompatible. Additionally, polyesters based on LA are 
approved for clinical use.
56, 111, 117
 LA based polymers eventually break down to monomeric 
lactic acid, which is metabolized through the tricarboxyclic acid cycle and eventually removed 
from the body as CO2 via the respiratory system.
9, 127
 This degradation behavior of the LA and 
DHAC poly(carbonate-ester)s is why the biomaterial was chosen for further controlled release 
studies.  
These new studies using LA-DHAC poly(carbonate-ester)s were performed to further 
understand the degradation profile of the biomaterial. The degradation of the copolymer into 
DHA was explored via the bicinchoninic acid (BCA) assay. Using the BCA assay’s ability to 
react with α-hydroxy ketones, a more complete degradation profile of DHA release from the 
copolymer was obtained.
128
 The controlled release behavior of proteins from the copolymer 
matrix was determined using two model proteins, bovine serum albumin (BSA) and lysozyme, 
loaded at two different weight percentages. Chosen for their well-documented behavior in other 
controlled release systems, the rate of release of the BSA and lysozyme was quantified using the 
Bradford microassay.
16, 111
 The activity of lysozyme was monitored by a biological activity assay 
to explore how the degradation characteristics of the copolymer might affect the structural 
stability of the released model protein. Mathematical modeling was used to analyze the 
mechanism of release of the proteins to obtain a better understanding of these poly(carbonate-
ester)s. 
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4.2 Experimental 
4.2.1 Materials 
All copolymer compositions are defined according to the following abbreviations: LAx = 
mol % lactic acid; DHACy = mol % dihydroxyacetone carbonate. Three mole ratios of 
copolymers, pLA50-co-DHAC50, pLA25-co-DHAC75, pLA15-co-DHAC85, were synthesized as 
previously described (Mw ~70,000 g/mol).
125
 Bovine serum albumin (BSA), lysozyme and M. 
lysodeikticus cells were purchased from Sigma-Aldrich (St. Louis, MO) and used as received. 
Phosphate buffered saline (10X, PBS) without calcium or magnesium was purchased from 
BioWhittaker
®
 (Lancaster, MA) and diluted to 1X with 18 Ω water. Potassium phosphate 
monobasic, potassium phosphate dibasic, and Costar Brand Serocluster 96-well microtitration 
plates were purchased from VWR (West Chester, PA). BCA Protein Assay kit (product number 
23225) was purchased from Thermo Scientific
®
. Quick Start
™
 Bradford Protein Assay 1X Dye 
Reagent (catalog number 500-0205) was purchased from Bio-Rad Laboratories, Inc.  
 
4.2.2 Copolymer degradation analysis 
Tablets were formed from the three copolymer ratios via direct mechanical compression 
of the copolymer powder using a Carver Press, model 3851-0 (Wabash, IN). The copolymers 
were first sized through a 250 μm sieve before direct compression of 20 mg of copolymer at 
1000 psi for 10 seconds at room temperature. The tablets were placed in 1X PBS buffer solution 
(1.0 mL, pH 7.4) and incubated with rotation (N=3) at 37 ºC in 1.5 mL Eppendorf tubes. At 
predetermined time points, the entire buffer solution was isolated and replaced with fresh buffer. 
The majority of the removed buffer was immediately frozen, while a small aliquot was run under 
standard BCA conditions according to the manufacturer’s directions: 50:1 bicinchoninic acid and 
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tartrate in an alkaline carbonate buffer (reagent A) to 4% copper sulfate pentahydrate solution 
(reagent B). The relative intensity of the reading was determined at 562 nm on a SpectraMAX 
Plus384 Microplate Reader (Molecular Devices Corporation).  
 
4.2.3 Protein release quantification 
Two different loading percentages of each protein, 5% and 10% by weight, were passed 
through a 250 μm sieve. The fine powder was then incorporated into the three different 
copolymer matrices, also sized through a 250 μm sieve, via geometric dilution with the 
copolymer powder. 20 mg of the subsequent mixture was then subjected to direct mechanical 
compression using a Carver Press, model 3851-0 (Wabash, IN) to 1000 psi for 10 seconds at 
room temperature to form tablets. The final cylindrical tablets had dimensions of approximately 
5.32 ± 0.02 mm x 0.84 ± 0.02 mm (diameter x thickness) as measured by digital calipers. The 
tablets were placed in 1X PBS buffer solution (1.0 mL, pH 7.4) and incubated with rotation 
(N=3) at 37 ºC in 1.5 mL Eppendorf tubes. At predetermined time points, the entire buffer 
solution was exchanged and a 150 μl aliquot of appropriately diluted buffer sample placed in a 
clear polystyrene 96 well plate. To this was added 150 μl of Quick Start™ Bradford Protein 
Assay 1X Dye Reagent and the solution allowed to shake for two minutes before sitting at room 
temperature for 8 additional minutes. The relative intensity of the solution was determined at 595 
nm on a SpectraMAX Plus384 Microplate Reader (Molecular Devices Corporation). The 
remaining buffer removed at each time point was immediately placed in a freezer set to -20ºC.  
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4.2.4 Activity assay 
The biological activity of lysozyme was determined using M. lysodeikticus (0.01% w/v) 
suspended in potassium phosphate buffer (66mM, pH 6.24) freshly prepared from potassium 
phosphate monobasic and potassium phosphate dibasic crystals. A 15 μl aliquot of appropriately 
diluted released protein sample was placed in a 96 well plate and mixed with 200 μl of prepared 
M. lysodeikticus suspension. The plate was immediately placed in a SpectraMAX Plus384 
Microplate Reader (Molecular Devices Corporation). The decrease in the absorbance was 
monitored by the UV spectrophotometer over a 5 minute period (450 nm, 25ºC). The activity of 
the lysozyme, defined in enzyme units (EUs) was determined using the slope of the linear 
portion in the plot of absorbance versus time.
129, 130
 A unit of enzyme was defined as the quantity 
of enzyme that caused an absorbance decrease of .001 per minute at pH 6.24 (66 mM potassium 
phosphate buffer) and 25ºC. The biological activity of the sample was then compared to the 
native lysozyme sample to evaluate the effect of the formulation. If a 15 μl sample gave too 
weak of a signal, a 50 μl or 100 μl sample was used and compared to corresponding volumes of 
native lysozyme samples.  
 
4.2.5 Protein release modeling 
Modeling of protein release was conducted in Graphpad
©
 using the mean values of the 
three samples from each time point. Models with the best fit had a correlation coefficient (r
2
) 
closest to 1.0. The data for the Korsmeyer-Peppas model was only fit to approximately the first 
60% of the fraction released as required by the model.
40
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4.3 Results and Discussion 
4.3.1 DHA release from pLAx-co-DHACy 
Previous work explored the degradation behavior of pLAx-co-DHACy copolymer over an 
8 week study (Chapter 2). This study tracked the loss of mass from the polymers at set time 
points. The results of this study showed that the carbonate bond appeared to be more labile to 
hydrolysis than the ester bond.
125
 This behavior led to the copolymers with more DHAC, and 
subsequently more carbonate bonds in the backbone, to degrade more rapidly than those with 
more lactic acid. Also, the degradation of those tablets showed a behavior that aligned with many 
of the characteristics indicative of surface erosion as evidenced by scanning electron microscopy. 
However, due to the insolubility of the copolymers in common solvents, an accurate profile for 
the change in molecular weight and monomer release was unable to be obtained at that time.  
To further explore the manner in which these pLAx-co-DHACy copolymers degrade, a 
new study was run under similar conditions to capture the change in monomer composition 
during degradation. Recently, we discovered that structures with an α-hydroxy ketone 
arrangement are quantifiable using the BCA assay (Chapter 3).
128
 This assay is applicable due to 
α-hydroxy ketone’s ability to form an enediol through a process that subsequently reduces the 
copper present in the BCA assay. The reduction of the copper in turn causes a colorimetric 
response by the bicinchoninic acid present. Due to DHA’s ability to form this enediol, the release 
of DHA from the copolymer is able to be tracked using the BCA assay.  
Three copolymers with monomer ratios were synthesized, pLA50-co-DHAC50, pLA25-co-
DHAC75, pLA15-co-DHAC85, by varying the amount of initiator to obtain copolymers with a Mw 
~70 kDa, as previously reported. The copolymer powder was formed into tablets via direct 
compression and placed into 1.5 mL Eppendorf tubes containing 1.0 mL of 1X PBS buffer. The 
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samples were then allowed to rotate at 37 °C to simulate in vivo conditions. At set time points, 
the entire volume of buffer was exchanged and the removed buffer assayed using the BCA assay 
for the presence of DHA.  
The results, shown in Figure 4.1, follow the same trends as previously seen with the mass 
loss studies of these materials. The data, which is normalized to 100% DHA loss when the tablet 
completely eroded away, show the pLA15-co-DHAC85 to degrade the fastest. This ratio shows an 
almost zero order release of DHA from the backbone up to day 30, a pattern that may indicate a 
surface erosion type degradation behavior. What is more telling is that in a direct comparison of 
the percent release of monomer to the percent mass loss of the tablet from previous studies, the 
behavior is almost directly aligned, as seen in Figure 4.1. This result may signify a material with 
more surface eroding characteristics, but is not the only mechanism of erosion.  
The monomer release for both pLA50-co-DHAC50 and pLA25-co-DHAC75 showed slower 
degradation profiles whose linear portion, up to day 45 for pLA25-co-DHAC75 and day 76 for 
pLA50-co-DHAC50, follow first order release kinetics. This result implied a more bulk erosion 
pattern is responsible for the degradation of the copolymers. While this type of degradation does 
not perfectly align with surface erosion, the release of the DHA in these two ratios is fairly 
consistent and controlled. Also, there is no burst release of the DHA from the material which is 
generally seen with bulk eroding polymers made of lactic acid. It should also be noted that the 
release of DHA, while reduced in magnitude, continued until the tablets had completed eroded 
away. As seen in Figure 4.1, a direct comparison of the percent release of monomer from pLA25-
co-DHAC75 and pLA50-co-DHAC50 to the percent mass loss of the tablet shows similar behavior, 
but they are not perfectly aligned. The curves for these two ratios begin to show a more rapid 
loss of DHA after 10% of the DHA released. Once 10% of the DHA is released, the mass loss of 
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the tablet diverges from the amount of DHA that is released and would appear to indicate that 
bulk erosion is more responsible for the copolymer degradation.  
 
 
 
 
 
Figure 4.1. Fractional percent release of DHA from the copolymer matrix directly compared to 
the percentage mass loss, both as a function of degradation time (n=3).
125
 (A) pLA15-co-DHAC85 
(B) pLA25-co-DHAC75 (C) pLA50-co-DHAC50 
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4.3.2 Analysis of bovine serum albumin release 
After monitoring how the copolymeric material behaves under in vitro degradation 
conditions, two model proteins were selected to monitor the release behavior from the copolymer 
matrix. Due to its well characterized behavior in release studies, BSA was incorporated into the 
copolymer matrix prior to tablet formation. To evaluate factors that affect the in vitro release, 
two different protein loading percentages, 5% and 10% by weight, were chosen for the study. 
Throughout the study, BSA was quantified using the Bradford microassay and the protein loaded 
copolymers kept in near sink conditions via the complete exchange of buffer no later than every 
24 hours.
131, 132
  
For all ratios, the release of the protein from the copolymer matrix follows a first order 
release pattern, with the pLA15-co-DHAC85 releasing the fastest and the pLA50-co-DHAC50 
being the slowest, seen in Figure 4.2. This occurrence is expected due to previous degradation 
studies, which showed erosion occurring much more rapidly in the copolymers with more DHAC 
in the backbone.
125
 However, the release profiles of BSA do not perfectly align with the mass 
loss of any of the copolymer ratios. This result, coupled with the new understanding of monomer 
release from the copolymers, indicates the materials show more bulk degradation characteristics. 
If this is the case, then some of the well defined rules in which proteins release from bulk 
degrading LA based polymers may be applicable to these poly(carbonate-ester)s. 
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Figure 4.2. Fractional release percent of BSA and lysozyme compared to fractional release of 
monomer from the copolymer matrix as a function of time (n=3). BSA (●), lysozyme (□), 
fractional monomer release (▲). (A) pLA15-co-DHAC85, 5 wt% loading (B) pLA15-co-DHAC85, 
10 wt% loading (C) pLA25-co-DHAC75, 5 wt% loading (D) pLA25-co-DHAC75, 10 wt% loading 
(E) pLA50-co-DHAC50, 5 wt% loading (F) pLA50-co-DHAC50, 10 wt% loading. 
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 During the release of a protein from PLGA based systems, there are three phases 
observed. An initial release of protein due to surface bound or poorly encapsulated drug through 
aqueous pores, a second phase attributed to diffusional release through pores or through the 
dense polymer, and a third phase generally regarded as release due to erosion of the polymer 
matrix.
117, 133-135
 The earlier onset of erosion impacts the formation of pores in the matrix, which 
is generally regarded as the release mechanism for similar LA based matrices.
56, 135
 However, the 
diffusional release may also be due to the protein’s diffusion through the polymer, osmotic 
pumping, or erosion of the encapsulating polymer. Yet, it is the transport through pores in the 
matrix that is the most common method of release due to the fact that transport of higher Mw 
molecules, such as peptides, are too large and too hydrophilic to transport through the polymer 
phase. Also, a protein may release from the polymer matrix before any mass loss is observed. 
Directly comparing these poly(carbonate-ester)s with the release of BSA from PLGA 
tablets and microspheres under similar conditions, there appears to be a similar in vitro release 
behavior. A study done by Bodmer, et al., exemplified this type of system with BSA released 
from directly compressed PLGA tablets with a range of molecular weights, up to 76,000, as seen 
in Figure 4.3.
133
 The PLGA tablets (55:45 lactic acid:glycolic acid) had a 20 wt% BSA loading 
and showed bulk erosion type of degradation. The release from these tablets showed an initial 
burst of ~28%, which is slightly higher, but comparable to the DHAC based matrices, which had 
~20% release of protein in the first hour. This initial burst release was true of all of the ratios and 
loading percentages, except for the 10 wt% loading of pLA15-co-DHAC85, which released ~40% 
of the BSA within the first hour. The initial burst effect, generally attributed to the rapid 
diffusion of protein located at or near the surface of the polymer matrix, usually is increased by 
higher loading percentages.
56, 117, 136
 The higher loading percent of pLA15-co-DHAC85 and the 
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fact that this copolymer ratio begins to degrade much more rapidly than the other ratios of 
DHAC based copolymers, may explain the higher initial burst. Comparing the initial burst of the 
DHAC based copolymer to Bodmer’s PLGA polymers appear to be in agreement due to 
Bodmer’s higher loading percent of protein. However, comparing the DHAC based tablet to 
PLGA microspheres show a large difference in the initial burst effect. Certain PLGA 
microspheres showed ~10% initial burst for less than 2% protein loading by weight, while 
studies done with 10 wt% BSA loading saw a 30-58% initial burst. Furthermore, both of these 
studies saw the classic problem of slow, incomplete protein release.
117, 136, 137
 The higher initial 
burst seen in the microsphere preparation is generally attributed to the manner in which they are 
made and are highly dependent on the solvents used in preparation, method of fabrication, and 
release medium.
56, 136-140
 
 
 
 
Figure 4.3. Comparison of release properties of BSA and lysozyme from pLAx-co-DHACy 
systems as compared to PLGA systems.   
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Bodmer, et al., also observed that the PLGA release system showed near complete release 
of the protein from the matrix before the system lost any mass, as seen in Figure 4.3. This 
behavior is typical of the bulk degradation of higher molecular weight lactic acid based tablet 
matrices, while low molecular weight polymers may begin to lose mass immediately.
133, 141
 Both 
the DHAC and PLGA systems of comparable molecular weight had similar protein release 
profiles and close to 100% protein release, however the manner in which these PLGA matrices 
degrade is quite different than the DHAC based polymers. What is interesting about the similar 
protein release profiles for PLGA and these DHAC based copolymers of comparable Mw is that, 
unlike studies involving PLGA based polymers, the mass of the DHAC based tablet decreases 
from the onset of the study. This phenomenon was observed previously and is shown in Figure 
4.1.
125
 However, through GPC analysis of PLGA polymers, there is a noticeable molecular 
weight change in the polymers starting at day 0, showing the polymer backbone degradation 
begins upon the onset of the study.
10, 50, 133
 This occurrence was tracked for the DHAC based 
copolymers using BCA analysis of the monomer produced from the degrading copolymer 
backbone and the same conclusion drawn. These findings suggest that the pores that form in the 
DHAC based polymers from the onset not only help to transport the protein out, but may help 
transport degraded LA and DHA from the polymer matrix. Another piece of evidence that 
supports this theory is the fact that the copolymers do not form a liquid core. This phenomenon is 
seen during the degradation of PLGA based polymer tablets due to the buildup of lactic acid and 
subsequent pH decrease.
10, 56, 57, 71, 140
 Due to the pore formation, we hypothesize that the pH of 
the DHAC based copolymers stays more neutral under sink conditions, which leads to a more 
amenable environment for the therapeutics being delivered. All of this evidence suggests that the 
manner in which proteins release from the DHAC based polymers does not exactly follow the 
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three phase system of release like that of PLGA matrices.  
In contrast, PLGA microspheres show less efficient cumulative protein release, as seen in 
Figure 4.3. As shown in Figure 4.2, the DHAC based materials have an 80% or greater release 
efficiency, while studies by Igartua, et al, used PLGA microspheres (50:50, Mw ~30k-70k, 10 
wt% loading) and only saw a cumulative release of BSA of less than 80%, with the lowest being 
40%, over a 45 day study.
137
 Other work reported protein aggregation within the microspheres 
that led to a significant reduction in the percent of BSA released.
136, 139, 142
 This protein 
aggregation was quite pronounced in the studies done by Viswanathan, et al., who saw only a 
7.5% release of BSA from PLGA microspheres (70:30, Mw ~74.5k, 2 wt% loading) over an 
extended study.
136
 At the end of the 250 day study, an insoluble mass of protein equivalent to 
78.9% of the total BSA loaded into the microspheres was extracted from the remaining PLGA 
microspheres. This reduction in the total release of encapsulated proteins is widely observed by 
many researchers and is attributed to the degradation or aggregation of the protein within the 
degrading polymer matrix or during microsphere preparation.
117, 136, 139, 140
 There are a number of 
theories as to why the degradation or aggregation of the protein occurs within the microspheres, 
which include formation of intermolecular linkages, the formation of non-specific physical or 
chemical adsorption between polymer and protein, or the hydrolysis of the protein. These 
reasons may explain why the release from the DHAC based copolymers did not show 100% 
recovery of BSA. 
 
4.3.4 Analysis of lysozyme release 
The release of lysozyme from the copolymer matrix was done in the same manner and 
under the same conditions as the release of BSA. Shown in Figure 4.2, the release of lysozyme 
86 
 
generally followed the same release profile as that of the BSA. However, the release was more 
controlled and the point at which the release of lysozyme began to slow down tended to be closer 
to the total percent released as compared to the BSA. This phenomenon, commonly seen in drug 
release, is attributed to the increasing difficulty of the protein or drug from the center of the 
tablet to diffuse out of the matrix, as a result the release rate will begin to slow down.
143, 144
 The 
lysozyme release study also had a higher percent of total release than the BSA, with all of the 
ratios and loading percentages having a greater than 95% total release, as seen in Figure 4.2. 
Furthermore, the lysozyme release saw a consistent, slightly lower initial burst amount between 
14-21% of the total drug for all of the samples. The difference in initial burst is possibly due to 
the difference in chemical and physical properties of each protein that affected the initial 
release.
143
 
A key aspect of the lysozyme release study was to monitor the biological activity of the 
protein and assess how the degrading copolymer matrix affected the protein. Over the course of 
the study, the lysozyme’s activity remained fairly high for most of the study. In the studies using 
the pLA15-co-DHAC85 ratio, the activity of the lysozyme was quite high, with the 5 wt% loading 
having about a 69% activity and the 10 wt% loading having about 87%. This trend of the 10 wt% 
loading showing higher activity was seen for all the ratios and is attributed to the fact that the 10 
wt% loading tablets normally released the protein faster than the 5 wt% loading. The release 
from the pLA25-co-DHAC75 copolymer ratio saw about a 72% and 75% biological activity for 
the 5 wt% and 10 wt% loading, respectively. However, the pLA50-co-DHAC50 ratio had much 
lower activity values, approximately 15% and 14% for the 5 wt% and 10 wt% loading, 
respectively. This lower activity, as compared to the other two ratios, is attributed to the longer 
lysozyme release profile. The pLA15-co-DHAC85 and the pLA25-co-DHAC75 ratios release in less 
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than a third of the time that the pLA50-co-DHAC50 ratio releases lysozyme. Also of note is that 
pLA50-co-DHAC50 kept ~50% of its activity for the first 37 days in the 5 wt% loading and 42 
days in the 10 wt% loading. These findings suggest that the environment created by the 
degradation of the LA and DHAC within the matrix is not excessively harsh on sensitive proteins 
located in the interior.  
Comparing the release of lysozyme from this system to that of PLGA microspheres, 
again there was seen a lower cumulative release efficiency in the system, as seen in Figure 4.3. 
In studies done by Viswanathan, et al., PLGA microspheres (80:20, Mw ~45000, 1.6 wt% 
loading) saw a similar release profile to that of BSA.
136
 Over the time course of this study there 
was only a 5.7% release of lysozyme and at the end of 250 days, a 90.7% insoluble mass of 
lysozyme was recovered from the microspheres. A second study with the same PLGA 
microspheres containing ~5 wt% loading of lysozyme showed a slightly higher cumulative 
release of about 13%. Both of the release experiments showed the released lysozyme was still 
biologically active. Other studies by Park, et al., saw similar cumulative release values. PLGA 
microspheres (50:50, Mw ~8600, ~10 wt% loading) showed less than 10% lysozyme release 
over 25 days, the majority of which came from the initial burst effect followed by a very slow 
release. However, this study found that lysozyme had very little biological activity compared to 
the native over the 25 day period.
145
  
 
4.3.5 Mechanism of release 
Theoretically, the release mechanism of the model proteins from these matrices relies on 
the penetration of the dissolution fluid into the matrix through pores, the dissolution of the 
soluble component of the matrix, and the transport of the drug out of the matrix into the bulk 
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dissolution medium.
35, 37-39, 135, 146, 147
 To understand the mechanism that controls the release of 
protein from the copolymer matrices in vitro, five commonly used models were used to fit the 
data; the zero-order equation, the first-order equation, the Higuchi equation, the Hixson-Crowell, 
and the Korsmeyer-Peppas models. The zero-order equation describes the release of a drug as 
independent of concentration.
33, 148
  
                                                           tkC O                                                                   (1) 
Where C is the concentration of drug released, kO is the zero-order rate constant, and t 
represents time. 
The first-order equation, which implies the release rate is concentration dependent, is 
used to describe drug dissolution in dosage forms containing water soluble drugs in porous 
matrices.
33, 148
  
                                                  
303.2
loglog
kt
CC O                                                     (2) 
Where C is the concentration of drug released, CO is in initial concentration of drug, k is 
the first-order rate constant, and t represents time. 
 
The Higuchi equation is a Fickian based diffusion model that describes the release of a 
drug from an insoluble matrix as a square root of time dependent process. The model is used to 
describe drug release of water soluble drugs from non-swellable or dissolvable matrices and a 
high correlation indicates drug release via diffusion.
35
 
                                                           2/1tkQ H                                                               (3) 
Where Q is the percent of drug released, kH is the rate constant of the Higuchi system, 
and t represents time. 
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 The Hixson-Crowell model, which models the release from a matrix that has changing 
surface area or diameter of particles or tablets, is applicable to systems in which dissolution 
occurs in planes that are parallel to the drug surface if the matrix dimensions diminish 
proportionally.
36
 A high correlation using this model indicates protein release by dissolution and 
with changes in surface area and diameter of the tablets. 
                                                      tkQQ HCtO 
3/13/1                                                        (4) 
Where QO is the initial amount of the drug, Qt is the amount of drug released at time t, 
kHC is the rate constant of the Hixon-Crowell system, and t represents time. 
 
The Korsmeyer-Peppas model is a semi-empirical equation that uses a power law 
expression to describes the drug release from a swelling controlled system.
37-39, 149
 
                                                           nt kt
M
M


                                                               (5) 
Where Mt/M∞ is the fraction of drug released at time t, k is the rate constant of the 
Korsmeyer-Peppas system, t represents time, and value of n is used to characterize the release 
mechanism for cylindrical shaped matrices. The n value indicates the manner of protein release, 
either by Fickian diffusion, a combination of diffusion and matrix erosion, or solely by erosion 
of the polymeric matrix. A summation of the n values and the mechanisms associated with these 
values is found in Table 4.1. 
 
Upon fitting the data to these five models, the best fit of the release data was with the 
Korsmeyer-Peppas model, seen in Figure 4.4. This model is used when the release mechanism is 
not well known or when more than one type of release (diffusion, erosion, or swelling) controls 
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the system. The r
2
 values for both BSA release and lysozyme release have the highest correlation 
with this model compared to the others and the values are located in Table 4.2 and 4.3. The value 
of n calculated using the model gives an idea of the mechanism of release and is found in Table 
4.4. For the pLA15-co-DHAC85 copolymers loaded with either 5 wt% or 10 wt% of BSA or 
lysozyme, the n value for a cylindrical shape is within the 0.89 > n > 0.45 range, indicating an 
anomalous or non-Fickian transport mechanism.
40
 When n = 0.45 or n = 0.89, a Fickian or Case 
II transport mechanism is observed for this system, respectively. Non-Fickian or anomalous 
diffusion occurs when the diffusion and relaxation rates are comparable and is associated with 
the rate at which the structure of the polymer rearranges to accommodate water molecules.
40, 150
 
This transport is partially controlled by viscoelastic relaxation of the polymeric matrix as water 
penetrates the system. In Case I, or Fickian diffusion, the mobility of the penetrant is much 
slower than the segmental relaxation rate. In Case II diffusion, the mobility of the penetrant is 
much higher than the segmental relaxation rate. Non-Fickian diffusion contains intermediate 
characteristics of both Case I and Case II diffusion and depends on the polymer-penetrant 
system, the penetrant activity and the temperature.
40, 151
 Deviation from Fick’s law is observed 
when the penetrant diffusion is at a temperature below the glass transition (Tg) temperature.
151
 
This is the case for all of these poly(carbonate-ester)s, which have Tg values around 60 °C.
125
  
The other ratios and loading percents fell outside of the anomalous transport region, with 
values less than 0.45. These n values indicate a pseudo-Fickian release mechanism. This pseudo-
Fickian behavior suggests that the release mechanism is quite complex, and may depend on 
numerous other factors such as drug diffusion, porosity, the crystallinity, polymeric swelling, and 
polymer erosion.
147, 152, 153
 Pore distribution and size greatly affects the release rate of the drug as 
it follows a tortuous path through the matrix. The pore arrangement intrinsic to the system may 
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explain one trend seen with the pLA50-co-DHAC50 and pLA25-co-DHAC75 matrices. In general, 
the n value increased with increasing loading percent, which may be a function of the increased 
number of pores created in the system as the protein diffused out. The formation of pores is due 
to void spaces created by the solubilized protein or by the erosion of copolymer matrix which is 
a rate-controlling process.
135
 Another observed trend for the pLA50-co-DHAC50 and pLA25-co-
DHAC75 is the values of n decrease as the LA content within the copolymers increased. This 
may correlate to the possibility for increasing crystalline microdomains within the copolymer 
matrix that affect the mechanism of transport.  
For all of the ratios, statistical effects that pertain to the differences in polymer and drug 
distribution throughout the system may lead to deviations from the ideal Fickian behavior.
147, 154
 
The degradation of the copolymer’s backbone, visualized using the BCA assay to track the 
release of degraded DHA from the copolymer backbone, may decrease the rigidity of the 
polymer chains and alter the porosity of the degrading polymer tablet.
133, 135, 147
 There is also 
increasing hydrophilicity of the polymer due to an increase in the number of terminal carboxylate 
and hydroxyl end groups from a build up of monomer degradation. This monomer build up is 
much more rapid in the pLA15-co-DHAC85 as compared to the pLA50-co-DHAC50 and pLA25-co-
DHAC75 ratios. The increase in hydrophilicity leads to an increase in solubility of the 
undissolved polymer and thus the porosity of the matrix. However, in the copolymer ratios with 
more LA, there is an increase in the carboxylate end group as compared to the hydroxyl end 
group. The increase in carboxylate end groups may interact with the positively charged proteins 
or other cationic structures, thus impeding their release.
117, 126, 133, 135, 140, 155
 If this is the case, the 
release of protein from pLA15-co-DHAC85 may not only be due to faster copolymer degradation 
kinetics, but because it has the least number of ionizable groups compared to the other 
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copolymer ratios containing more LA.  
The increase in the number of ionizable groups also aligns when comparing the release of 
BSA to the release of lysozyme. As seen in Figure 4.2, lysozyme releases slightly slower than 
BSA. This observation is most evident when directly comparing the graphs of the 10 wt% 
loading. Due to the increase in carboxylate end groups from the degrading LA, coupled with the 
possibility that the pH of the system may decrease, the positively charged lysozyme (pI 11.35) 
may be attracted to the carboxylate groups while the negatively charged BSA (pI 4.7) is 
repelled.
156, 157
 The attraction of lysozyme to the degrading lactic acid based matrix was 
previously noted in studies by Park, et al., when salt was needed to break up the ionic interaction 
of the protein and matrix in an attempt to raise the total percent of lysozyme released.
145
 Thus, 
the BSA would release faster from this copolymer matrix. 
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Figure 4.4. The calculated trend lines of the Korsmeyer-Peppas model overlaid on the fraction 
release percent of protein from the three copolymer ratios: pLA15-co-DHAC85 (●), pLA25-co-
DHAC75 (■), and pLA50-co-DHAC50 (▲). (A) 5 wt% loading of BSA (B) 10 wt% loading of 
BSA (C) 5 wt% loading of lysozyme (D) 10 wt% loading of lysozyme. 
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Table 4.1. Korsmeyer-Peppas drug transport mechanism from cylindrical polymer matrices. For 
clarity this table has been repeated from Table 1.1. 
 
 
Table 4.2. Calculated kinetic parameters from fitting the release of BSA from the pLAx-co-
DHACy copolymer matrix to the five different release models (k is the release rate constant and 
r
2
 is the correlation coefficient). 
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Table 4.3. Calculated kinetic parameters from fitting the release of lysozyme from the pLAx-co-
DHACy copolymer matrix to the five different release models (k is the release rate constant and 
r
2
 is the correlation coefficient). 
 
 
 
 
Table 4.4. Calculated Korsmeyer-Peppas values of the exponent, n, and release mechanism for 
the release of BSA and lysozyme from the pLAx-co-DHACy copolymer matrix.  
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4.4 Conclusion 
Various poly(carbonate-ester)s based on lactic acid and a carbonate form of 
dihydroxyacetone were formed into tablets via direct compression. The degradation of these 
copolymer matrices was explored using the BCA assay to track DHA release from the copolymer 
backbone. A trend toward faster DHA release was seen in the copolymers with more DHAC in 
the backbone and that the release of the monomer followed a similar trend as that of mass loss 
for each tablet. However, the deviation of percent monomer released compared to percent mass 
loss indicates bulk degradation may play a more important part in the degradation of the 
copolymer matrix. 
The poly(carbonate-ester)s unique intrinsic characteristics, such as the increased 
degradation rate with copolymers more rich in carbonate bonds and the apparent lack of a 
viscous core formation due to lactic acid build up in the interior of the tablet, influence they way 
in which they release therapeutics. This degradation pattern makes for a more amenable 
environment for the release of sensitive proteins, as evidenced by the release of two model 
proteins, BSA and lysozyme. The poly(carbonate-ester)s achieved greater than 80% release for 
both model proteins at both 5 wt% and 10 wt% loading. The release of lysozyme had high levels 
of activity for the duration of release from pLA15-co-DHAC85 and pLA25-co-DHAC75, and 
greater than 50% activity for the first month of release from pLA50-co-DHAC50. It was seen that 
the release of both proteins fit the Korsmeyer-Peppas model with a high correlation, which may 
indicate that the release mechanism is a combination of diffusion and erosion based release. 
These poly(carbonate-ester)’s non-ideal Fickian behavior is greatly affected by the protein’s 
diffusion, the matrix’s porosity, the crystallinity of the polymers, polymeric swelling, and 
polymer erosion. 
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CHAPTER 5 – CLIMB GK-12 FELLOWS: BRINGING BME TO THE K-12 
CLASSROOM 
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5.1 Introduction 
The ability to successfully convey new ideas and concepts, particularly those regarding 
science and math, is an essential component to developing new teaching pedagogies.
158-161
 The 
Cornell Learning Initiative in Medicine and Bioengineering (CLIMB) is part of the National 
Science Foundation’s (NSF) GK-12 program which allows science, technology, engineering, and 
math (STEM) graduate students to understand this new facet of scientific education. The CLIMB 
program offers graduate students the chance to be visiting scientific scholars to area kindergarten 
through 12
th
 grade (K-12) schools, be scientists-in-residence and bring the graduate fellows’ 
research to the classroom. The scientific knowledge and experience that each fellow is able to 
share with area K-12 students may begin to bridge the gap between classic text book learning 
and the practical tools of laboratory science. A STEM Fellow’s presence in the classroom has the 
potential to enhance the content of the basic K-12 science curriculum.  
The GK-12 program allows STEM Fellows the opportunity to prepare lectures, provide 
demonstrations, become a mentor, expand on traditional lessons and implement a multi-day 
inquiry based experiment to highlight practical, relatable applications of the required curriculum. 
The tools and resources available to a BME graduate student unites math, chemistry, biology, 
medicine and engineering in such a way that opens K-12 students to new perspectives on 
science. The NSF GK-12 program also benefits the graduate fellow by improving on basic 
communication and teaching skills by challenging their abilities to relay scientific knowledge to 
an audience with a much less in-depth scientific background.  
 
5.1.1 Classroom background 
The aforementioned work in the CLIMB program partnered the STEM Fellow with Laura 
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Austen, a teacher for the New York State biology course entitled, The Living Environment. 
During the 2009-2010 academic year, the student traveled to Southside High School in Elmira, 
NY to help teach this New York State Regent’s level course. Student enrollment was 
approximately 90 students spread over 4 classes, with students ranging from 13-17 years old. 
 
5.2 Example lessons 
5.2.1 Viscoelastic polymers 
To introduce the field of polymer science, the students were asked to create Silly Putty. 
This viscoelastic polymer demonstrated the properties of both a viscous material and an elastic 
material. An overview was given of the basic structure of what comprises ordinary glue and how, 
in the presence of borate ions, the polymer structure crosslinks to create the abovementioned 
viscoelastic structure. This activity was done simply by mixing glue (mainly polyvinyl acetate) 
with borax (borate ions). The protocol used required preparing a supersaturated solution of Borax 
in tap water. To this was slowly added a 1:1 glue:tap water mixture, with constant stirring, to 
achieve the proper consistency. 
 
5.2.2 Physical properties of polymers 
Another polymer-based experiment involved the creation of bouncy balls. This 
experiment did not produce the best example of a bouncy ball (ie. the balls didn’t bounce as well 
as store bought ones), but it was feasible with the limited resources of the classroom. The 
experimental protocol is as follows: 
 
Pour 2 tablespoons warm tap water and 1/2 teaspoon borax powder into a cup. Stir the 
mixture to dissolve the borax and add food coloring, if desired. Pour 1 tablespoon of glue 
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into a different cup. Without stirring, add 1/2 teaspoon of the borax solution previously 
prepared and 1 tablespoon of cornstarch. Allow the ingredients to sit for 10-15 seconds 
and then stir them together to fully mix. Once stirring becomes ineffective, take it out of 
the cup and mold the ball with your hands. 
 
5.2.3 Hydrogels  
Another short polymer demonstration included exploring everyday polymers. A number 
of diapers were brought in and the students were asked to open them up and separate out the 4-5 
grams of a polyacrylic acid polymer found within the cotton layers. To give the students a basic 
understanding of hydrogels and hydrophilic polymers, tap water was added to about 2 grams of 
the polymer. The students then observed the material swell to about 50 times its original size. 
After the material reached its fullest size, a salt solution was added to the beaker and the students 
observed the polymer shrink back down. Aligned with this day’s demonstration, there were a few 
other polymeric materials Ms. Austen had on hand that offered other examples of polymeric 
hydrogels. One material, Instant Snow Polymer, when hydrated mimicked the appearance of 
snow, while Water Gel Crystals took on the appearance of cubes of ice when hydrated.  
 
5.2.4 Alginate  
To try and make a real world connection between polymers and everyday life, a talk was 
given about joint replacement and this topic tied into the food concept of molecular gastronomy. 
An explanation was provided about how people in biomedical research create scaffolds upon 
which to create new biologically inspired devices by borrowing two medial meniscus molds 
from the Bonassar lab at Cornell University. To demonstrate how these molds work, a 2% w/w 
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solution of both alginate and calcium sulfate was prepared. These solutions were injected in a 2:1 
alginate to calcium sulfate mixture into a mold and then the mold immediately submerged into a 
solution of calcium chloride for 20 minutes. To explore how these polymeric scaffolds are 
affected by the experimental conditions, the students varied the alginate/calcium sulfate mixtures 
to see how this would change the “tissue’s” properties. Following this, a link was provided 
between this type of medical laboratory science to cooking by demonstrating how, when the 
alginate is rapidly dropped into calcium sulfate, it forms a gel. However, if done right, the inside 
remains a liquid while only a thin outer layer becomes a gel. This example was then tied into 
how a number of restaurants around the world use this and other laboratory techniques to 
redefine fine dining experiences with science.  
 
5.2.5 Non-Newtonian fluids 
Another laboratory demonstration involved showing the students the properties of non-
Newtonian fluids. To teach the student’s about non-Newtonian fluids, a substance colloquially 
known as “oobleck” was created using 1 part tap water to 1.5-2 parts corn starch. This 
experiment was a huge success with the students and had far greater participation than most 
other experiment. A number of students even commented on trying this experiment at home.  
 
5.2.6 Cells and microscopy 
In the very beginning of the year a short talk on cells was aligned with their unit 
regarding this subject. A number of pictures of cells taken with different imaging techniques 
were shown to try and exemplify how they are a dynamic, living, 3-D structure. Along with this 
presentation, an explained was provided regarding the basic concepts of microscopy, specifically 
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scanning electron microscopy, and its usefulness in research. A number of actual pictures taken 
from one of Cornell’s SEM machines were shown to the students as well as Au/Pd sputter coated 
samples. The students were then asked to compare non magnified samples to ones magnified 
15,000 times.  
 
5.2.7 Properties of bone 
During the student’s unit on the human body, a short demonstration was provided on the 
properties of bones. The students were given turkey bones that were either demineralized with 
1M HCl overnight or had the organic components (collagen and elastin) removed using bleach 
overnight. This visually grabbing and tactile experiment caught the student’s attention 
immediately. It was effective in explaining how bones are not the completely rigid materials that 
most people assume.  
 
5.2.8 Heart valves 
During this demo, a number of different porcine and bovine heart valves were brought to 
the classroom. A talk was given about the different kinds of heart valves and the surgery that 
would be required to implant such a device. This lesson had a large majority of the students 
interested due to the personal connections some made with these materials and the knowledge 
that family members have these devices implanted.  
 
5.2.9 Biomedical devices 
Another hands on talk was about different biomedical devices. A variety of medical 
devices such as endoscopes, different models of pacemakers used throughout the years, and 
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internal defibrillators were brought in to show the students the evolution of medical devices. The 
student’s learned about how the devices have changed with time and what things might impact 
the newer technologies (i.e. better microprocessors). 
 
5.2.10 Biochemistry 
During the unit on biochemistry, a discussion about pH and different methods to assess 
this intrinsic property of certain materials was held. In an attempt to have the students think 
about the tools they have in their everyday environment, a head of red cabbage was brought to 
the classroom. The cabbage was cut up and boiled for 20 minutes. Upon cooling, the extracted 
liquid was used as a pH indicator. The student’s were taught that this liquid was a pH indicator 
because it contains the anthocyanin, flavin. In the presence of very acidic solutions it will turn 
anthocyanins a red color. Neutral solutions are a purplish color, like the extracted color from the 
cabbage, and basic solutions will be greenish-yellow. This experiment was also the first time the 
students started questioning everyday objects they use, such as their sodas, cleaning spray, etc.  
Another activity that was created with different biochemistry techniques in mind was a 
Thanksgiving themed laboratory involving the concepts of lipids, proteins, carbohydrates, and 
pH. To help reinforce mandatory New York State laboratory requirements, the students took all 
of the components found in a traditional Thanksgiving meal and decided which food (turkey, 
gravy, stuffing, pumpkin pie, etc.) and what test (starch test with iodine, Benedict’s solution for 
sugar, etc.) they would like to perform. Due to this activity being relatable, a larger number of 
students became more involved as compared to other standard laboratory assignments that were 
trying to exemplify the same concepts 
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5.2.11 Ideal gas law 
In another attempt to teach the students science in a non-traditional manner, dry ice was 
provided to the students. The goal was to show them sublimation and how gases expand. To do 
this, dry ice was added to a lab glove, sealed, and the students observed its expansion. Also, dry 
ice was added to water to watch it bubble as the gas escaped. However, the biggest thrill for them 
was when a tiny bit of dry ice was added to a 1.5mL Eppendorf tube filled with tap water and 
capped. On top of the fun popping noise, it showed them that the expanding gas caused enough 
pressure to build up to uncap the tube, thus subtlety teaching them the ideal gas law, PV=nRT. 
A final experiment brought in involved the use of liquid nitrogen to try and once again 
examine the ideal gas law. The students used liquid nitrogen to condense the air/moisture in a 
blown up balloon and then watched it re-expand when removed from the liquid nitrogen. Other 
items, such as flowers and bananas, were flash frozen to show how the liquid trapped inside 
these materials can freeze and cause seemingly solid objects to shatter when dropped. Finally, 
the students used the liquid nitrogen to make ice cream in an attempt to not only have fun, but 
also open them up to new ideas and other ways of thinking about common items in the world 
around them. This experiment showed them that the faster the rate of undercooling of a material, 
the smaller the new forming crystals will become, thus creating a creamier ice cream that they 
had never tasted before. 
 
5.3 Inquiry-based curriculum development 
Part of the CLIMB program involved the development of an inquiry-based experiment. 
The work in this thesis focuses on the unit of genetics and teaching two inquiry-based laboratory 
experiments on gel electrophoresis. The goal of the first experiment was to have students 
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understand how gels are made for DNA separation and how altering the composition can affect 
the experimental parameters and mechanical properties of the gel. A module template for the 
agarose electrophoresis mini experiment can be found in the Appendix A.1. The goal of the 
second experiment was to run a SDS-PAGE electrophoresis to compare known and unknown 
protein samples. The experiment itself was designed by Cornell Institute of Biology Teachers 
(CIBT) and gave the students an opportunity to employ SDS-PAGE to compare different animal 
proteins, figure out an unknown “mystery meat” sample, and answer their own questions (ie. 
how similar are fresh water fish vs. salt water, etc.).  
During both the agarose gel mini lab and the SDS-PAGE four day lab, the feedback from 
students was overall very positive. During this unit it was found that more students who normally 
do not ask questions or participate were more active and engaged within their lab group 
throughout the experiment. This was especially true while loading the gels with their protein 
samples. In the beginning, more than half the students said they did not want to participate. 
However, upon seeing their classmates use micropipetters to load the gels, all of the reluctant 
students began vying for the chance to load protein samples into the acrylamide gel.  
However, it should also be noted that this experiment was not a 100% inquiry-based 
success. Due to the lack of inquiry-based labs in their daily curriculum, many students struggled 
with the experiment design being so open ended. They had difficulty devising a question they 
would want to explore about the different types of meat and then designing an experiment to 
answer said question. Regardless of its average success rate for student comprehension of 
inquiry-based science, an overall positive response was observed for the majority of the students.  
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5.4 Data analysis  
To quantify the impact that my presence had during the year, two metrics were used to 
assess their science and math knowledge and attitude. Both of these metrics were administered 
before the STEM Fellow began at Southside High School and at the end of the school year to 
student’s with which the Fellow interacted and students with which Fellow had no contact. A 
fourteen question, basic science inventory was created drawing from the concepts of other 
educational designed metrics.
162, 163
 The first 10 questions were designed to assess the scientific 
knowledge of the students and the last 4 questions were designed to assess their attitude toward 
math and science (A.2) These first 10 questions were designed to include basic concepts that are 
incorporated into the NY State Reagent’s level biology course and new areas of knowledge the 
STEM Fellow wished to cover during their time at Southside High School. The second metric 
was the draw a scientist test (DAST), which is a method in which to assess the student’s attitude 
toward science and scientists.
164
 The manner in which these scientists are drawn (i.e. what they 
look like, any symbols of science in the picture, etc.) give an indication toward the student’s 
attitude towards the members of the scientific community. 
Analyses were conducted to investigate whether students’ knowledge of science and 
attitude toward science changed during the school year as a function of having a STEM Fellow 
present in the classroom. In order to examine these questions, 2 x 2 mixed design analyses of 
variance (ANOVAs) were run, with time as a within-subjects variable (pre- and post-school 
year) and class as a between-subjects variable (Laura Austen’s class with a STEM Fellow 
present and a control class). Main effects of time and class were explored, as well as a time x 
teacher interaction. It was hypothesized that a STEM Fellow’s presence in the classroom would 
positively impact the student’s breadth and depth of scientific knowledge, as well as their 
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attitude toward science. Only students who completed both the pre-test and post-test were 
included in the analyses that follow. 
 Students completed a 10-question knowledge of science survey at the beginning and end 
of the school year. These questions were administered at both assessments and are found in 
appendix 2. There was a statistically significant main effect of time, such that students’ mean 
score on the science knowledge survey was higher at the end of the school year (M = 1.74, 
standard error (SE) = 0.32) than at the beginning of the school year (M = 0.44, SE = 0.14), F(1, 
41) = 19.56, p < .0001. There was also a statistically significant main effect of class, with the 
mean knowledge score for students in the class with the STEM Fellow (M = 1.69, SE = 0.21) 
being greater than the mean knowledge score for students in the control class without the STEM 
Fellow (M = 0.49, SE = 0.33), F(1, 41) = 9.52, p = .004. These main effects were qualified by a 
statistically significant time x class interaction, F(1, 41) = 16.56, p < .0001. Paired samples t 
tests were conducted to examine the change in students’ knowledge of science from the 
beginning to the end of the school year in each class separately. As predicted, students in the 
class with the STEM Fellow showed a statistically significant increase in knowledge of science 
from the beginning of the school year (M = 0.44, SE = 0.14) to the end of the school year (M = 
2.94, SE = 0.39), t(30) = -7.00, p < .0001. In contrast, there was no significant change in 
knowledge of science over the school year for students in the control class without a STEM 
Fellow, t(11) = -0.58, p = .58 (Mbeg = 0.44, SEbeg = 0.24, Mend = 0.54, SEend = 0.15). This 
interaction is depicted in Figure 5.1.  
Similar changes over the course of the school year were observed in students’ attitude 
toward science. There was a statistically significant time x class interaction, F(1, 44) = 4.85, p = 
.03. As above, the interaction was evaluated by conducting paired sample t tests for change in 
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attitude over time for each class separately. In the class with the STEM Fellow, there was a 
significant increase in students’ attitude toward science from the beginning of the school year (M 
= 2.55, SE = 0.25) to the end of the school year (M = 3.16, SE = 0.14), t(30) = -3.26, p = .003. 
This pattern of results is consistent with students viewing science more positively over time. 
Throughout the course of the school year, the students’ appeared more engaged in the in-class 
activities and State required laboratories. In contrast, there was no significant change in students’ 
attitude toward science in the control class without the STEM Fellow from the beginning of the 
school year (M = 2.95, SE = 0.23) to the end of the school year (M = 2.70, SE = 0.35), t(14) = 
0.61, p = .55. While there was a decrease in the control class’s attitude toward science, this was 
not statistically significant and may be due to random fluctuations. These results are shown in 
Figure 5.2.  
The second metric used to assess the student’s attitude toward science was the DAST. 
The original criteria of the DAST included items such as the presence of a lab coat or eyeglass, 
symbols of research or knowledge, or any relevant captions.
164
 However, only two criteria were 
used to assess the Southside High School DAST results. It was hypothesized that the presence of 
a younger, female STEM Fellow might impact the student’s attitude toward the scientific 
community. Therefore, the DAST results were evaluated using a chi-squared test for age and 
gender of the scientist depicted in their drawing. The results show a statistically significant 
change in their perception of what characteristics are associated with scientists, with a drop from 
approximately 90% considering scientists as male to almost an even ratio of male to female by 
the end of the school year, as shown in Figure 5.3 (χ2 = 15.99, df = 1, p<0.0001). The age of the 
scientific figure in the drawing also saw a statistically significant shift from figures that looked 
older in the initial drawings, to younger figures in the final drawings (χ2 = 6.134, df = 2, 
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p=.0465). Examples of these drawings can be seen in Figure 5.4.  
The students were also asked to write who they think scientists are before meeting their 
STEM Fellow and again at the end of the school year. The results of asking the question, “who 
are scientists?”, also saw a shift in perception. Out of 72 students who answered this question 
before the presence of a STEM Fellow, approximately 11% used wording that they are normal 
people or implied this descriptor. However, this number rose to 44% when this question was 
answered by 50 students at the end of the school year. A more qualitative assessment of the 
student’s answers saw another shift from answering the question with words and phrases that 
only used symbols of scientists, such as lab coat or goggles, to answering the question with 
phrases like, “you and I”, “Ms. Austen or Ms. Weiser”, or “anyone”. 
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Figure 5.1. Science knowledge pre-school year and post-school year for the classes that 
interacted with a STEM Fellow and a control class 
 
 
 
 
Figure 5.2. Attitude toward science pre-school year and post-school year for the classes that 
interacted with a STEM Fellow and a control class.  
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Figure 5.3. Assessment of gender and age of the responses pre- and post-school year to the 
“Draw a Scientist Test”.   
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Figure 5.4. Examples of responses pre- and post-school year to the “Draw a Scientist Test”. 
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5.5 Conclusion 
The GK-12 experience was overall a positive one. The ability to interact with young 
students benefits both the STEM Fellow, by improving communication skills, and the students, 
who had a positive experience by the presence of a STEM Fellow in the classroom. The 
implementation of inquiry-based learning and more “hands on” lessons attempted to enhance the 
state designed curriculum for the biology-based, The Living Environment, high school course. 
The responses of students to the question, “has your view on science changed throughout the 
year?”, were overall very positive. Students gave responses such as, “My views for science have 
changed because I have been taught a whole new perspective”, “My views of science changed a 
lot. After taking this class I want to get involved in science as a career”, and “Science can be 
fun… not boring”. Of course not every student appeared to benefit from a STEM Fellow in their 
classroom, but to the majority of students, the presence of a STEM Fellow appeared to help 
supplement their high school science experience. 
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CHAPTER 6 – FUTURE DIRECTIONS 
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6.1 Introduction 
The focus of future work using dihydroxyacetone as a copolymer component is to 
continue to elucidate the structure-function relationship of new DHA based copolymers. This 
work will include the synthesis of new copolymers based on DHA with both glycerol and 
various diacid alkanes (DAs) in the backbone as well as continued work on MPEG-pDHAC 
copolymers. The overall goal is to be able to understand how DHA incorporated into a 
copolymer backbone will affect its intrinsic characteristics and subsequently be able to harness 
certain aspects for new biomaterial-based medical devices.  
 
6.2 Diacid alkanes 
The goal of the first work is to understand the effect of adding a free hydroxyl, as well as 
the introduction of alternate esters into the polymer backbone, will have on the polymer’s 
intrinsic characteristics. The synthesis of DHA and DA copolymers has been initiated and their 
usefulness as biomaterials studied.
165, 166
 We hypothesize that by varying the type and ratios of 
the monomers within the copolymer backbone that we can study the structure/function 
relationship of each component within the material and ultimately create new biomaterials based 
on DHA. 
In an effort to further harness DHA’s inherent characteristics, such as its ability to form 
Schiff bases that can be reduced to secondary amines, or its ability to act as a physical 
crosslinker to make a gel if the polymer is too water soluble, the synthesis of alternate 
copolymers should continue to be explored.
20-22
 The decision to incorporate both glycerol and 
diacid alkanes (DAs) into the polymer backbone is due to their inherent characteristics that both 
provide. Glycerol, an tri-alcohol monomer, is a very desirable building block to use for creating 
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polyesters or poly(carbonate-ester)s because it has a history of being biocompatible, is FDA 
approved and inexpensive. Polymers containing glycerol also have in a secondary hydroxyl 
group in the backbone that can hydrogen bond and is amenable to further functionalization.
 51, 54, 
167-169
 On the other hand, diacid alkanes, such as sebacic acid, a diacid monomer, are a natural 
metabolic intermediate in ω-oxidation from medium to long chain fatty acids.19 Like glycerol, a 
variety of diacid alkane containing polymers have also been approved by the FDA for medical 
applications and shown to be safe in vivo.
18, 170, 171
 The potential DA’s have a long history of 
biocompatibility, easily undergo hydrolytic degradation, and have wide range of applications, 
such as controlled drug delivery devices or use in medical devices such as biodegradable 
elastomers.
19, 51, 170, 171
 Despite well-established work involved in the synthesis of poly(glycerol-
sebacate) materials, these materials are crosslinked thermosets. The ability to synthesize linear 
polymers with a reactive, physical crosslinking site, promoted the proposed exploration of 
polyesters derived from adipoyl chloride, sebacoyl chloride, or suberoyl chloride polymerized 
with dihydroxyacetone and glycerol. The addition of the glyerol’s free hydroxyl is an intriguing 
candidate to add to the polymer backbone making this three component copolymer an attractive, 
potentially bioadhesive, material to study.
165, 166, 172
  
 
6.2.1 Preliminary synthesis 
To synthesize copolymers based on DHA, glycerol, and DAs, a Schötten-Baumann, one 
step acylation was carried out. The synthetic scheme, based on one previously used to create 
poly(DHAx-co-DAy) copolymers, is shown in Scheme 6.1.
165, 166
 Briefly, DHA (0.350 g, 3.89 
mmol) and glycerol (0.358 mg, 3.89 mmol) were charged to a 10 mL airfree single neck reaction 
flask fitted with a 2 mm stopcock and magnetic stir bar stored at temperatures above 100 ºC. The 
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flask was kept under N2 flow at temperatures below 0 ºC during the addition of an organic 
solvent (chloroform, or a chloroform/dimethyl sulfoxide mixture are both candidates to address 
solubility and freezing point issues) (15 mL). The solution was allowed to stir before the slow 
addition of the diacid chloride (DC), ex. sebacoyl dichloride (0.83 mL, 3.89 mmol) at a syringe 
rate of 1 mL per minute. After which, pyridine (0.75 mL, 9.31 mmol) was added via syringe at 
the same rate. Following the addition of all of the reagents, the N2 flow was stopped, the reaction 
vented and the reaction allowed to proceed for thirty minutes.  
 
 
 
 
Scheme 6.1. Proposed synthetic route to p(DHAx-co-DAy-co-GLYz) (IV). a) chloroform/DMSO, 
pyridine, N2(g), -78ºC, 30 minutes. 
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The material synthesized precipitated out of solution as the reaction proceeded and the 
resulting polymers were moderately adhesive to the touch. This behavior is indicative of the 
formation of a networked polymer that is crosslinked. These crosslinks were formed due to the 
reaction of the secondary alcohol in the glycerol monomer, as well as the primary alcohols. 
However, the intent was to create linear polymers using this one step synthesis. One change to 
the synthetic protocol that may help to achieve this goal is to reduce the temperature further by 
the use of an acetone/dry ice bath. The addition of dimethly sulfoxide to the chloroform enables 
the temperature to be reduced close to the -78 ºC an acetone/dry ice bath achieves due to 
chloroform’s freezing point residing at -63.5 ºC. The end goal is to synthesize a library of 
different mole feed ratios at two different molecular weights and with three different diacid 
chlorides (adipoyl chloride, sebacoyl chloride, and suberoyl chloride) to help understand how 
each monomer contributes to the function of the copolymer as a whole (Table 6.1). 
 
 
 
*DC denotes adipoyl chloride, sebacoyl chloride, and suberoyl chloride 
 
Table 6.1. Potential prepared mole feed percents of p(DHAx-co-DAy-co-GLYz) copolymers.  
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6.3 MPEG-pDHAC based copolymers 
The goal of the second work was to attempt to increase the time it takes for the MPEG-
pDHAC, diblock copolymer to degrade. Earlier work on this copolymer was effective in the 
treatment of seroma, however, the material’s original application was designed for use in post 
surgical tissue adhesions. The copolymer did not properly address this issue due to its rapid 
degradation in vivo.
20-22
  
Two different approaches to accomplish this are by end-capping the DHAC portion of the 
copolymer backbone and by incorporating LA into the copolymer to create a tripolymer. The 
copolymer of MPEG-pDHAC gave positive results for the potential creation of a biomaterial that 
is useful as a physical barrier to effectively reduce post-operative tissue adhesion. Post surgical 
tissue adhesion is a complex inflammatory disorder that occurs when tissues in the body grows 
into each other. These adhesions normally occur within the peritoneum after abdominal surgery; 
however, they may also form from infection, burns, irradiation, trauma, allergic reactions, 
repeated peritoneal dialysis, and the presence of debris.
27, 173, 174
 Post surgical abdominal tissue 
adhesions are a significant a factor in the onset of chronic abdominal and pelvic pain, perforated 
bowel, infertility, and small bowel obstruction.
27, 173, 174
 Abdominal adhesions also may require 
secondary surgeries that increase the total cost to the hospital and the patient over $2 billion 
dollars annually in the United States alone.
175, 176
  
To create an effective post-operative adhesion physical barrier, the material should be 
biocompatible and absorbable, remain in place without sutures or staples, cover and separate raw 
or injured surfaces, prevent fibrin strand formation, and be easy to handle during application.
27, 
173, 174
 Previous work has seen that MPEG-pDHAC holds promise as a physical barrier, however, 
this material degrades in less than 24 hours, while the material should last 48 to 72h in vivo.
21, 22, 
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27, 173, 174
 The hypothesis is that the terminating alcohol group from DHAC may be catalyzing the 
rapid degradation of the copolymer backbone, effectively “unzipping” the copolymer leading to 
its rapid degradation. Work with the previous, DHAC and LA based poly(carbonate-ester)s 
would seem to indicate that the degradation should be slightly slower for DHAC based materials. 
Therefore, the process of end-capping the MPEG-pDHAC or incorporation of LA into the 
backbone may increase the time in which the copolymers take to degrade. 
 
6.3.1 Preliminary synthesis 
The synthetic strategy to create the two potential new copolymers, the end-capped 
version of MPEG-pDHAC or the MPEGx-(pLAy-co-DHACz), can follow the same synthetic 
scheme as previous described by Zawaneh, et al and can be seen in Scheme 6.2 and 6.3.
21, 22
  In 
short, dihydroxyacetone dimer (II) can be converted to a ring by first locking the C2 carbonyl 
using a dimethoxy acetal protecting group. Structure III can then ben cyclized to a six member 
ring (IV). Structure VI can then be created via the polymerization of structure IV with a 5000 Mw 
polymer of monomethoxy-polyethylene glycol (V) in the presence of Sn(Oct)2 and heat. In the 
case of the MPEGx-(pLAy-co-DHACz) copolymer, LA will be added during this step. The 
copolymer can then be deprotected using TFA and water or I2/acetone to potentially afford 
structure VII (poly(MPEG-b-2-oxopropylene carbonate); MPEG-pDHAC).  
Based on other work, the end-capping of the DHAC and ultimate creation of structure 
VIII in Scheme 6.2, may be possible by using acetic anhydride in the presence of pyridine or a 4-
dimethylaminopyridine (DMAP) catalyst.
177-180
 The amount of time and temperature would need 
to be explored to find out the optimum conditions for this end-capping reaction to proceed 
forward. The work would also focus on optimizing the DHAC block length to understand and 
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control the copolymer’s degradation characteristics. 
 
6.4 Structural characterization 
The employment of similar characterization techniques to those of the previously made 
poly(carbonate-ester)s will help to understand the inherent properties of these potentially new 
materials. GPC can be used to analyze the molecular weight and molecular weight distribution of 
each sample synthesized. 
1
H NMR and 
13
C NMR can help to confirm the structure and determine 
the distribution of monomers within the polymer backbone. Thermally characterization 
techniques, such as thermogravimetric analysis detect the degradation temperatures of the 
samples while differential scanning calorimetry determines the glass transition temperature and 
the presence of a melting temperature. 
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Scheme 6.2. Proposed synthetic route to end-capped MPEG-pDHAC (VIII). a) trimethyl 
orthoformate, p-toluene sulfonic acid, methanol, 24 h; sodium carbonate, 24 h. b) 
ethylchloroformate, triethylamine, tetrahydrofuran, 3 h. c) stannous octoate, 100ºC, 1-2 h. d) 
trifluoroacetic acid, water, 12 h, room temperature or I2, acetone, 1h, reflux. e) acetic anhydride, 
pyridine or DMAP. 
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Scheme 6.3. Proposed synthetic route to MPEGx-(pLAy-co-DHACz) (V). a) stannous octoate, 
130ºC, 1-2 h. b) trifluoroacetic acid, water, 12 h, room temperature or I2, acetone, 1h, reflux. 
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6.5 Mechanical characterization 
Following these structural characterization methods, studies regarding the physical nature 
of the polymers should commence. To estimate how long the copolymers may remain within an 
in vivo environment, studies similar to those conducted with the p(LAx-co-DHACy) copolymers 
will be performed. The copolymers could be incubated in PBS (pH 7.4, 37ºC) and PBS (pH 7.4, 
37ºC, 1% esterase) for pre-determined time points (n=3). The use of this second PBS solution 
with the added esterase will be important to mimic how enzymes may affect the material’s 
degradation and can begin to mimic in vivo conditions.
22
 Upon sample recovery, the materials 
can be lyophilized and the change in mass and dimension recorded. If these polymers are soluble 
in THF or other common organic solvents, GPC studies to track the molecular mass loss could 
also occur. If not, the BCA assay may once again be used to determine the rate at which 
degraded DHA is leaving the copolymer backbones 
Another mechanical characterization method could be designed to explore the tissue 
adhesion kinetics of the polymer to quantify its bioadhesive behavior, which could be the 
ultimate goal of this class of biomaterial. These experiments could yield data on the Young’s 
Modulus and the yield point (i.e. mechanical characteristics) of the copolymers. Previous in vitro 
models to test the effect of varying amounts of DHAC within the copolymer have already been 
established.
181
 Additionally, the tissue adhesion kinetic studies, derived from earlier protocols, 
are able to mimic organ tissues surfaces, the origin of post-operative tissue adhesions. To 
accurately create the model tissue surface, collagen Type I derived from bovine calf skin could 
be cast and allowed to adhere to glass microscope slides. The adhesion characteristics can then 
be quantified by tensile strength analysis (Instron). The Young’s modulus and yield strength of 
the adhesion layer could be determined on different samples at various time points to produce a 
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strength vs. time profile for each polymeric material. 
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A.1 GK-12 genetics module 
Introduction to Agarose Gel Electrophoresis: A 
Precursor to CIBT’s DNA Profiling or Protein Gel 
Electrophoresis laboratories 
Author:   Jennifer Weiser and Laura Austen 
Date Created:  2010 
Subject:  Molecular Biology and Genetics 
Level:  High School 
Standards:  New York State- The Living Environment 
(http://www.emsc.nysed.gov/ciai/mst/pub/livingen.pdf) 
Standard 1: Inquiry and Design 
Standard 4.2.1: Genetics  
Schedule:  One 90 minute class period 
 
 
Objectives: 
To introduce students to the concepts of 
gel electrophoresis without requiring all 
the equipment needed to run a full gel 
electrophoresis experiment. The goal is 
to have students understand how gels 
are made for DNA separation and how 
altering the composition can affect the 
experimental parameters.   
 
Students will: 
 
 Mix and pour agarose gels of 
varying consistencies  
 Predict how changing the percent 
agarose will effect the outcome 
 Practice micropipetting  
 
 
Vocabulary: 
Gel Electrophoresis 
Gel Chamber 
Micropipette 
 
 
Buffer 
Agarose 
 
Materials: 
For Each Pair: 
 
2-3 grams agarose  
100 ml 1x Tris/Borate/EDTA (TBE) Buffer 
Gel casting tray and comb 
High walled container to (plastic box, tray, 
etc) 
0-20 μl micropipette (for every 3-4 pairs) 
Water 
Hot/stir plate (for every 3-4 groups) 
Erlenmeyer flask 
Stir bar 
Balance (for class) 
Food coloring 
Gloves 
Goggles 
 
Safety: 
 
All students should use gloves and goggles. 
Caution should be used while heating and 
dissolving agarose in TBE buffer.  
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Science Content for the Teacher: 
Gel Electrophoresis is a technique widely used in professional laboratory settings. There 
are a number of types of electrophoresis, but one of the most basic is that of agarose gel 
electrophoresis. This technique is used in laboratories all over the world to separate DNA based 
on size. To do this, a sample of DNA is amplified millions of times using Polymerase Chain 
Reaction (PCR) and then cut up into smaller segments using restriction enzymes. This DNA 
sample is then loaded into an agarose gel using a micropipette and exposed to an electric current. 
This current causes the DNA to move along the gel away from the negative electrode (anode) to 
the positive (cathode). This movement is impeded by the agarose gel’s composition, separating 
the DNA solely based on size (molecular weight). A molecular weight marker is often also used 
for later comparison. Once run, a visualization technique can be used to see the bands of 
different sized DNA along the gel. 
Agarose: Agarose is a linear polymer that is derived from red algae. Upon mixing with 
buffer and allowed to set, a gel matrix forms. This matrix, which can be thought of as a rubber 
band maze, impedes the flow of DNA. Larger DNA fragments become more entangled and take 
longer to move through this matrix while the smaller fragments can navigate through the pores of 
the matrix more easily. By adjusting the concentration of agarose used in the gel you can 
manipulate the porosity (size and number of holes). The more concentrated the gel, the smaller 
the pores and thus DNA would take longer to move. Larger fragments would not move as far 
through the gel, however, this would cause a better separation of smaller sized (lower molecular 
weight) DNA fragments. Conversely, the less concentrated the gel, the faster the fragments will 
move through the gel. This change in gel concentration would result in poorer resolution 
between the smaller DNA fragments since there are more pores through which the may move. 
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DNA: Deoxyribonucleic acid, DNA, is essentially the blue prints for all living organisms. 
DNA is a polymer based on four repeating nucleotides that is arranged in a double helix. Due to 
the inherent negative charge of these nucleotides, DNA is a negatively charged molecule. It is 
this feature that allows gel electrophoresis to separate the pieces of DNA based only on size. 
PCR: Polymerase Chain reaction is a simple technique to make an exponential number 
of copies of the DNA in question. This is done to make it easier to visualize the DNA after the 
experiment has run. The basics of this technique are three stages that keep repeating until 
stopped. First the double strand is denatured or broken apart at a high temperature. Next extra 
free floating copies of the four nucleotides anneal or attach to each strand making a new, 
complimentary strand. Then these new, complimentary strands elongate or add more nucleotides 
to match the exact length of the strand it is copying. This process, as mentioned before, can go 
on indefinitely until the user stops the reaction or the reagents, such as the free floating 
nucleotides, run out. 
Restriction Enzymes: These are enzymes that target specific nucleotide sequences 
within the DNA. By being so specific, each strand of DNA is cut at the exact same place as all of 
the other copies made by PCR amplification.  
Molecular Weight Marker: This is a standard sample that has a known molecular 
weight for each fragment it contains. By comparing the sample you have run to the standard, you 
can get an approximate size for each of your DNA fragments. 
Micropipette: This is a very exact tool used by scientists to deliver a set amount of 
material. The pipette is variable and can deliver very precise amounts just by adjusting the value 
located on the side. When using the micropipette to deliver a DNA sample or in this lab’s case, 
colored dye, it is important not to pierce the agarose gel by going to far into the well each comb 
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has produced. It is also important not to inject the sample too violently or trapped air bubbles 
will push out the sample 
 
Preparation: 
1. Each group should have an Erlenmeyer flask with 100 ml 1x TBE buffer, gel casting tray 
and comb, gloves, and secondary container with walls higher than those of the gel casting 
tray.  
2. If TBE buffer can not purchased it can be made beforehand. To make a 5x concentrated 
TBE stock solution, which can be diluted to 1x later on, you must first create a 0.5 M 
EDTA stock solution. Weigh out 93.05 g EDTA disodium salt and dissolve this in 400 
mL deionized water. Adjust the pH to 8 using sodium hydroxide and then add more 
deionized water to equal 500 mL. In a separate container add 54 g tris base and 27.5 g 
boric acid to 900 mL deionized water. Add 20 mL of the EDTA stock solution previously 
prepared and add more deionized water to equal 1L. Dilute to 1x before using.  
3. Pre-heat the stir/hot plates prior to the beginning of class 
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Classroom Procedure: 
Engage (Time: 15 minutes) 
Show the students all of the electrophoresis equipment and micropipettes.  Let them 
know what an agarose gel is and how it works. Ask the students to predict what would happen if 
you would change the formula to make a standard 1% gel. Also, show the students the proper 
pipetting technique before the start of the experiment. This can be done while you are waiting for 
the gels to solidify. 
 
Explore (Time: 60 minutes) 
Split the students up into groups of 2 and have them go to a work station. Have each 
group decide on a different percent agarose gel to make. Allow each group to weigh out the 
proper amount of agarose on the balance and have them add it to their 100 ml of TBE buffer. Put 
the flask on the hot plate with a stir bar running slowly (Note: If you do not have a stir plate you 
can use a metal spatula to help stir it gently). Once the agarose has dissolved allow it to cool 
before pouring it into the gel tray. Add the comb and allow the mixture to solidify (at least 30 
minutes depending on the percent agarose in the gel).   
You can take this time to explain a little about the properties of agarose gels and how 
they are used in laboratories.  
Once the gels have set, have the students (with gloves on) feel the gels and compare their 
relative strengths. Ask them to see how their findings match up with their initial predictions.  
Optional: Have the students keep track of how long each percent gel takes to solidify.  
Place the gels in the secondary container and add enough water to cover the gel. 
Carefully remove the combs from the gels and have the students try to pipette 8 μl of food 
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coloring into the well.  
 
Explain (Time: 15 minutes) 
You can use the time during gel solidification to begin to explain the concepts of gel 
electrophoresis. After finishing the hands on part, have the students discuss how their initial 
predictions compared to what they actually observed. Then ask the students to try and explain 
how altering the percentage weight of the gel might affect a gel electrophoresis experiment.  
 
Assessment:  
The following rubric can be used to assess students during each part of the activity. The 
term “expectations” here refers to the content, process and attitudinal goals for this activity. 
Evidence for understanding may be in the form of oral as well as written communication, both 
with the teacher as well as observed communication with other students. Specifics are listed in 
the table below. 
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1= exceeds expectations  
2= meets expectations consistently  
3= meets expectations occasionally  
4= not meeting expectations 
 
 Engage Explore Explain 
1 Shows leadership in 
the discussion and 
offers creative ideas 
reflecting a good 
understanding of 
electrophoresis. 
Completes work 
accurately while 
providing an explanation 
for what is observed. 
Works very well with 
partner. 
Provides an in-depth 
explanation of findings, 
making connections with real 
world applications 
2 Participates in 
prediction and shows 
an understanding of 
gel electrophoresis. 
Completes work 
accurately and works 
cooperatively with 
partner. 
Provides clear explanation of 
findings. 
3 Contributes to the 
predictions, but 
shows little 
understanding of gel 
electrophoresis. 
Works cooperatively 
with partner, but makes 
some mistakes with the 
procedure. 
Provides a limited explanation 
of findings. 
4 Does not participate. 
Shows no 
understanding of 
laboratory concepts. 
Has trouble working with 
partner. Does little to 
complete the procedure. 
Is not clear in explanation of 
findings. 
 
Extension Activities: 
This lab is a precursor to Cornell’s Institute for Biology Teachers lab’s entitled DNA 
Profiling – Paternity Testing (http://cibt.bio.cornell.edu/labs/dl/DNAP.PDF) or Using Protein 
Gel Electrophoresis to Study Evolution (http://cibt.bio.cornell.edu/labs/dl/PGEL.pdf) 
 
Safety:  
All students must have on the proper safety equipment when working with the agarose 
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gels (goggles and gloves). Care should be taken when using the hot plate or removing the heated 
agarose/TBE buffer mixture.  
 
Acknowledgments: 
Dr. Shivaun Archer, Department of Biomedical Engineering, Cornell University 
Dr. Christopher Schaffer, Department of Biomedical Engineering, Cornell University 
Nev Singhota, Director of EPO, Cornell University 
135 
 
A.2 GK-12 Survery 2009-2010 
Biochemistry 
What is an organic compound? Can you name one example? 
 
What is a polymer? Can you name one example? 
 
What is an enzyme? What do we mean when we say enzymes are specific? 
 
How is a protein made? 
 
Physiology  
What is biomedical engineering? Name one application of current biomedical research. 
 
What is a biomaterial? Can you name one example? 
 
Name two components of bone and why do they make it unique? 
 
Cell 
What is chromatography? Can you name one type of chromatography? 
 
Genetics 
What is gel electrophoresis? Can you name one application? 
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What does polymerase chain reaction (PCR) do? 
 
Extra 
Do you use science in your everyday life? 
 
Do you use math in your everyday life? 
 
Do you think you will use science or math in your everyday life after high school? 
 
Would you be interested in a career in science or math?  
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